International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023)

Document Type : Editorial

Authors

1 Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

2 Centre On Drug Policy Evaluation, St. Michael’s Hospital, Toronto, ON, Canada

3 Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

4 HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Kerman University of Medical Sciences, Kerman, Iran

5 Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Keywords

Main Subjects

Full Text

Introduction

The International Journal of Health Policy and Management (IJHPM) is a peer-reviewed, gold open access, and scientific multidisciplinary journal, with a specific focus on health policy and management research. It serves as a platform that brings together specialists from various fields, including health policy, health management, health economics, epidemiology, public health, global health, and social and public policy into a dynamic academic environment. The journal aims to foster effective communication among policy-makers, health system researchers, decision-makers, legislators, practitioners, educators, administrators, students, and allied health professionals, facilitating collaboration and knowledge sharing within the research and healthcare delivery systems.

The IJHPM was founded by Dr. Akram Khayatzadeh-Mahani (Former Assistant Professor of Health Policy at Kerman University of Medical Sciences. She is currently an assistant professor at the University of Regina) in early 2013. Its first issue was published on June 25, 2013, marking its entry into the competitive international landscape. Approaching its 10th anniversary in June 2023, IJHPM has achieved notable milestones. Over this period, IJHPM published 12 volumes and 112 issues, including four special issues[1]. From 2013 to 2023, there has been a consistent growth in the number of monthly manuscripts submitted to IJHPM, with an average of 16 submissions in 2013 to 71 in 2023. Out of a total of 7107 submissions received, 1698 peer-reviewed articles were published in IJHPM, representing approximately 24% of the total submissions[2].

The journal’s papers are indexed in several abstracting and indexing databases, and they are highly regarded by scientists. IJHPM is currently indexed in various prestigious databases, including the Web of Science Journal Citation Reports (WoS JCR) (Social Sciences Edition), WoS Science Citation Index Expanded (SciSearch®), WoS Journal Citation Reports (Science Edition), WoS Social Sciences Citation Index®, WoS Current Contents® (Social and Behavioral Sciences), MEDLINE, Scopus, EBSCOhost, PubMed Central (PMC), and Directory of Open Access Journals (DOAJ). In June 2022, the WoS JCR released its last impact factor (IF) of 4.967, positioning IJHPM as the 10th-ranked journal out of 88 in the “Health Policy & Services” category. This achievement places IJHPM in the first quartile (Q1).

IJHPM was free of charge for eight years, from June 2013 to June 2021. However, in order to cover the expenses associated with editorial tasks, administrative support, technical tasks, and indexing services, we transitioned from the Green Open Access publishing model to the Gold Open Access. To facilitate publishing, we have taken into account discounts and waivers for authors from low- and middle-income countries (LMICs), students, and IJHPM reviewers.

An Overview of IJHPM’s Advances

 

Indexing and Abstracting Databases

In the beginning, the five-year vision was to be indexed in PMC, Medline, Scopus, and WoS by 2018. Therefore, we designed the journal’s processes and workflow, such as the peer review process, technical standards, and the website, based on the four abstracting and indexing evaluation criteria and also followed international and reputable guidelines like the International Committee for Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), and World Association of Medical Editors (WAME). Furthermore, the IJHPM’s editorial office continually evaluates the quality of processes and implemented some innovative actions to advance its rank among leading scientific journals. For instance, in order to standardize sex and gender reporting in research publications, we began incorporating the Sex and Gender in Research (SAGER) guideline1 into our author guide in May 2021 and encouraged our authors to follow it. In April 2023, we switched to the CRediT format in accordance with the updated technical requirements in PubMed for reporting the authors’ contributions.

The first goal of IJHPM was achieved remarkably quickly, within six months, as the journal gained visibility in PMC in 2014. The second goal was to secure indexing in MEDLINE, the largest and oldest biomedical database in the world,2 with more complex inclusion criteria compared to PMC, Scopus, and even WoS.3 To accomplish this, we followed specific policies to highlight the distinctive nature of our publication and set IJHPM apart from other journals in the same field. We established the knowledge translation line of IJHPM, which comprises two sections: ‘Key Messages’ and ‘Video Summary.’ In the ‘Key Messages’ section, authors of all original articles are requested to present the key findings of their research under two separate headings namely: ‘Implications for Policy Makers’ and ‘Implications for Public.’ Additionally, we introduced ‘Video Summary’ as another IJHPM knowledge translation activity. This initiative involves inviting authors of selected publications to prepare video summaries of their articles, which are then published on the IJHPM YouTube Channel. Currently, there are 157 videocasts and podcasts available on this channel. Simultaneously, we commenced efforts to attract new editorial board members, reviewers, and authors from around the world, with a particular emphasis on engaging individuals from resource-limited settings and LMICs. In 2015, our collective efforts paid off, and IJHPM was indexed in Medline as a young journal.

To accomplish our next set of goals, which included indexing in WoS and Scopus, we maintained a continuous effort to monitor and adhere to the evaluation criteria of these two databases. Additionally, we closely monitored the citation status of our journal in Google Scholar. Recognizing that citation metrics play a crucial role in the evaluation process of WoS and Scopus,4,5 we implemented new strategies to enhance the visibility and promotion of our published papers. In pursuit of this objective, we utilized various academic social networks, such as Academia, ResearchGate, LinkedIn, and Mendeley[3] to promote our published papers. Furthermore, IJHPM actively engaged with the wider public through popular social networks such as Facebook and Twitter, ensuring that all papers were promptly shared on these platforms following their online publication. Moreover, we encouraged authors to actively disseminate their papers among their own academic networks, expanding the reach and impact of our publications.

In 2016, the journal gained visibility in WoS Emerging Sources Citation Index (ESCI), marking a notable achievement. Subsequently, by 2017, IJHPM was accepted for inclusion in Scopus, further solidifying its position in the academic community. One of the primary objectives outlined in IJHPM’s five-year vision was to attain an official IF. This goal was successfully realized by the end of 2018, with the first IF of IJHPM being released by JCR 2019, garnering an impressive IF of 4.485. This achievement underscored the growing influence and impact of IJHPM within its field. The progress of IJHPM’s citation database has continued to thrive, culminating in its current ranking of 10th position in the field, as reported by JCR 2021. The persistent growth and recognition of IJHPM’s scholarly contributions are evident in its citation database progress. A graphical representation of the timeline progress of IJHPM is presented in Figure 1, offering a visual demonstration of the journal’s remarkable trajectory.

 

https://www.ijhpm.comdata/ijhpm/news/FullHtml/12/ijhpm-12-8124-g001
Figure 1. IJHPM Timeline in Abstracting and Indexing Databases. Abbreviations: ESCI, Emerging Sources Citation Index; JCR, Journal Citation Reports; IF, impact factor; WoS, Web of Science; SCIE, Science Citation Index Expanded; SSCI, Social Sciences Citation Index; IF, impact factor.



IJHPM Editorial Board Members and Staff

IJHPM has successfully attracted the collaboration of renowned scholars from around the world, who have established themselves as leading experts in their respective fields. Currently, our editorial board consists of 24 esteemed members, comprising eight women and 16 men, representing 12 countries across five continents. All members actively contribute to reviewing papers, writing editorial papers, and the exchange of ideas aimed at enhancing the overall quality of the journal. Over the past decade, these dedicated board members have played an instrumental role in publishing 69 editorial papers.6-83 Furthermore, IJHPM has published four special issue editorials,9,12,35,64 three guest editorials, and two joint global editorials on the climate change movement.7,8

Over the past decade, IJHPM has experienced several modifications in its editorial board and office members. However, the most notable change occurred in September 2021 when Dr. Akram Khayatzadeh-Mahani resigned from her position as the Editor-in-Chief after dedicating eight years (January 2013 to September 2021) to establishing and enhancing IJHPM’s reputation. Although her absence is deeply felt, IJHPM is grateful to have her ongoing support as the founding editor (October 2021-current).

In October 2021, Professor Ali-Akbar Haghdoost, the former director-in-charge of IJHPM, assumed the position of Editor-in-Chief at IJHPM. Alongside him, three new associate editors joined the IJHPM team to assist with daily editorial duties and work closely with the editorial office members. Currently, IJHPM has a team of five in-house editors, six staff members, and one consultant. The detailed information of editorial board members, in-house editors, and staff is presented in Table S1 (Supplementary file 1).

 

IJHPM Peer-Review and Publication Processes

Over the course of 10 years, IJHPM has contributed significantly to academic discourse by publishing a total of 1698 peer-reviewed articles. Throughout its publication history, IJHPM has featured a diverse range of scientific article types, with a total of 14 distinct categories. However, over time, six of these article types have been discontinued, resulting in the current selection of eight types that are presently published: editorial, viewpoint, review articles, original article, short communication, commentary, correspondence, and letter to editor. For a comprehensive overview of the distribution of each article type published by IJHPM over the past decade, refer to Figure 2.

 

https://www.ijhpm.comdata/ijhpm/news/FullHtml/12/ijhpm-12-8124-g002
Figure 2. IJHPM Article Types and Frequencies. * Since 2023, we have stopped publishing ‘Perspective’ articles. † Review articles consist of Systematic Review, Meta-Analysis, Systematic Reviews and Meta-Analysis, Meta-Synthesis, and Scoping Reviews. ‡ Since 2019, we have stopped publishing ‘Debate’ articles. § Since 2018, we have stopped publishing ‘Policy Brief’ articles. ¶ Since 2021, we have stopped publishing ‘Study Protocol’ articles. # Since 2015, we have stopped publishing ‘Book Review’ articles.

 

On average, IJHPM receives approximately 690 manuscript submissions annually with a 9% acceptance rate. Over the years, there has been a noticeable upward trend in the number of submissions, particularly since 2018 when the submission rate accelerated even further. Notably, the highest number of submissions was recorded in 2020, with a total of 1471 manuscripts received. This upward trend in submissions could potentially be attributed to the journal’s commendable IF score and increased visibility within the academic community. However, since 2021, there has been a decrease in the number of submissions, which may be linked to changes in the journal’s business model, including the implementation of article processing charges (APC) for authors. The submission trend of IJHPM is shown in Figure 3.

 

https://www.ijhpm.comdata/ijhpm/news/FullHtml/12/ijhpm-12-8124-g003
Figure 3. IJHPM Submission Trends From June 2013 to December 2022.

 

To ensure the high quality of published articles, the editor-in-chief and section editors of IJHPM conduct a thorough pre-screening of all submissions. This pre-screening process involves assessing the manuscripts for their methodological rigor, originality, contribution to knowledge and practice, as well as the use of English language. Based on the outcome of this pre-screening, manuscripts will be either fast rejected, sent back to authors for revision and resubmit, or sent for external peer review. Manuscripts that meet the IJHPM’s priority and quality criteria will undergo a double-blind peer-review process to evaluate the content quality. In the pre-screening stage, approximately 80% of IJHPM submissions are rejected, and only 20% proceed to the external peer review. This stringent selection process guarantees that only the highest quality and most relevant articles are considered for publication in IJHPM.

The IJHPM upholds a rigorous double-blind peer-review process that prioritizes speed, fairness, and the publication of high-quality articles. Reviewers, selected based on their scientific background, expertise, and authors’ recommendations, are required to disclose conflicts of interest and maintain strict confidentiality. The IJHPM strives to obtain at least two strong and comprehensive reviews for each manuscript. The Editor-in-Chief and section editors carefully consider reviewers’ comments and prepare decision letters, which undergo multiple rounds of review before final acceptance or rejection. Once accepted, the technical team will publish the author-accepted version of the manuscript (AAM) while producing the PDF proof. Publishing the AAM version expedites the dissemination of accepted manuscripts, making them available on the IJHPM website within three days of acceptance.

The journal currently follows an annual publication schedule, with any changes in publication frequency are shown in Figure 1. This meticulous process, combined with the commitment to transparency and prompt dissemination, ensures that IJHPM maintains its reputation as a premier platform for scholarly discourse in health policy and management.

 

Diversity of IJHPM Authors and Reviewers

The IJHPM has published articles from 5794 authors across 105 countries. The majority of authors are affiliated with the United Kingdom (n = 651), the United States (n = 649), Iran (n = 621), Canada (n = 590), and Australia (n = 543). Table 1 highlights the top 10 most productive authors.

 

Table 1. IJHPMs’ Top 10 Productive Authors
  Name Affiliation Country Number of Articles References
1 Mohammad Karamouzian University of Toronto Canada 17 50,84-99
2 Russell Mannion University of Birmingham UK 14 54,56-59,77,100-107
3 Ali-Akbar Haghdoost Kerman University of Medical Sciences Iran 14 40,50,62,86,88,90-93,108-112
4 Ronald Labonté University of Ottawa Canada 14 9,52,53,79,113-122
5 Martin McKee London School of Hygiene and Tropical Medicine UK 14 61,79,123-134
6 Patrick P. T Jeurissen Radboud University Medical Center The Netherlands 12 135-146
7 Leon Bijlmakers Radboud University Medical Center The Netherlands 12 10,34,147-156
8 Ruairí Brugha Royal College of Surgeons in Ireland Ireland 12 19,20,34,79,148,150,152,153,156-159
9 Fran Baum Flinders University Australia 11 119,122,160-168
10 Rob Baltussen Radboud University Medical Center The Netherlands 11 10,11,147,154,155,169-174

Since its inception in July 2013, the journal has established a dynamic platform that fosters global collaboration and facilitates discussions on contemporary issues through its commentary and correspondence line. This initiative invites scholars to contribute commentaries following the publication of various article types, such as original research, reviews, and editorials. The commentaries received are then compiled and shared with the main authors, who provide responses that are subsequently published as correspondence papers. These collections of commentaries and correspondence papers create a special compendium, enabling in-depth exploration of specific topics with contributions from scholars worldwide. From July 2013 to May 2023, a total of 136 collections have been published, encompassing 589 commentaries and 93 correspondence papers.

Since its establishment, the IJHPM has garnered the collaboration of 4339 reviewers from 108 countries. Notable, the majority of reviewers are from Australia (n = 280), Canada (n = 272), the United States (n = 260), the United Kingdom (n = 159), and China (n = 151). The selection process for reviewers employed by IJHPM is characterized by its unique approach, which involves comprehensive database searches to identify individuals with expertise relevant to the manuscripts under consideration. Invitations to serve as reviewers are then sent via the journal’s management system, with the goal of securing at least five agreements for research manuscripts and three agreements for short manuscripts. To achieve this goal, up to 50 reviewers may be invited per manuscript. The IJHPM’s global reach is reflected in the diverse backgrounds of its reviewers, as highlighted in Table 2, which showcases the top 20 reviewers.

 

Table 2. IJHPM’s Top 20 Reviewers
  Name Affiliation Country Number of Reviewed Manuscripts Average Time to Review (Days)
1 Aidin Aryankhesal orcid University of East Anglia United Kingdom 35 14
2 Mohammad Reza Baneshi orcid University of Queensland Australia 28 1
3 Martin McKee orcid London School of Hygiene and Tropical Medicine United Kingdom 25 20
4 Ghobad Moradi orcid Kurdistan University of Medical Sciences Iran 23 28
5 Mohammad Hajizadeh orcid Dalhousie University Canada 20 30
6 Joel Lexchin orcid York University Canada 17 1
7 Ehsan Zarei orcid Shahid Beheshti University of Medical Sciences Iran 17 4
8 Mohammad Karamouzian orcid University of Toronto Canada 13 27
9 Ronald Labonté orcid University of Ottawa Canada 12 4
10 Helen Schneider orcid University of the Western Cape South Africa 12 20
11 Krishna Hort orcid University of Melbourne Australia 11 19
12 Phillip Baker orcid Deakin University Australia 10 26
13 Philip Dalinjong orcid University of Technology Sydney Ghana 10 34
14 Matthew Fisher orcid University of Adelaide Australia 10 16
15 Gill Harvey orcid Flinders University Australia 10 39
16 Simon Rushton orcid University of Sheffield United Kingdom 10 21
17 Edwine Barasa orcid KEMRI-Wellcome Programme Kenya 9 50
18 Carlos Bruen orcid Royal College of Surgeons Ireland 9 8
19 Unni Gopinathan orcid Norwegian Institute of Public Health Norway 9 49
20 Dimitri Renmans orcid University of Antwerp Belgium 9 23

 

IJHPM Status in Citation Databases

Based on data from the WoS database, the IJHPM has received a notable total of 12 210 citations. The JHPM H-index in WoS is 41, and the average number of citations per article is 8.3. In the “Health Policy & Services” (SSCI) category, the IJHPM holds an impressive 10th position out of 88 journals, and in the “Health Care Sciences & Services” (SCIE) category, it ranks 20th out of 109 journals. Furthermore, the IJHPM has achieved a Q1 ranking in both categories, highlighting its prominence and impact in the field. The journal reached its highest IF of 5.007 based on the JCR 2020. Table 3 provides a comprehensive overview of the IJHPM’s IF trend and ranking data in WoS.

 

Table 3. IJHPM Impact Factor Trend and Ranking Data in Web of Science
  2-Year IF 5-Year IF JCIa Health Policy & Services (Quartile) Health Care Sciences & Services (Quartile) Cited Half-lifeb (y) Citing Half-lifec (y) Immediacy Indexd
JCR 2021 4.967 5.418 0.99 ranks 10 among 88 journals (Q1) ranks 20 among 109 journals (Q1) 3.6 6.4 1.787
JCR 2020 5.007 4.909 1.15 ranks 6 among 88 journals (Q1) ranks 13 among 107 journals (Q1) 3.6 6 4.533
JCR 2019 3.821 NA 1.16 ranks 7 among 88 journals (Q1) ranks 14 among 102 journals (Q1) 3.4 6.3 1.472
JCR 2018 4.485 NA 0.91 ranks 6 among 82 journals (Q1) ranks 12 among 98 journals (Q1) 2.8 8.4 1.66

Abbreviations: JCR, Journal Citation Reports; IF, impact factor; NA, not available; Q1, quartile 1.

aThe Journal Citation Indicator (JCI) is the average Category Normalized Citation Impact (CNCI) of citable items (articles & reviews) published by a journal over a recent three-year period. The average JCI in a category is 1. Journals with a JCI of 1.5 have 50% more citation impact than the average in that category. It may be used alongside other metrics to help you evaluate journals.

bThe Cited Half-Life is the median age of the items in this journal that were cited in the JCR year. Half of a journal’s cited items were published more recently than the cited half-life.

cThe Citing Half-Life is the median age of items in other publications cited by this journal in the JCR year.

dThe Immediacy Index is the count of citations in the current year to the journal that references content in this same year. Journals that have a consistently high Immediacy Index attract citations rapidly.

From 2013, the IJHPM amassed a significant total of 13 877 citations in Scopus. The IJHPM H-index in Scopus is 45, and the journal’s current CiteScore is 6.5, securing the top position among 36 journals in the “leadership and management” category. The IJHPM is listed in five subject categories in Scopus and is classified as a Q1 journal in all of them. Table 4 presents a detailed record of the IJHPM’s metrics in Scopus over time. Figure 4 shows the upward trend in citation rates for the IJHPM in both WoS and Scopus.

 

Table 4. IJHPM CiteScore trend and Ranking Data in Scopus
  CiteScore Leadership and Management (Quartile) Health Information Management (Quartile) Health Policy (Quartile) Health (Social Science) (Quartile) Management, Monitoring, Policy and Law (Quartile)
2021 6.5 ranks 1 among 36 journals (Q1) ranks 10 among 39 journals (Q1) ranks 20 among 265 journals (Q1) ranks 19 among 323 journals (Q1) ranks 54 among 376 journals (Q1)
2020 5 ranks 1 among 29 journals (Q1) ranks 8 among 39 journals (Q1) ranks 26 among 242 journals (Q1) ranks 24 among 293 journals (Q1) ranks 68 among 355 journals (Q1)
2019 3.5 ranks 3 among 31 journals (Q1) ranks 10 among 33 journals (Q2) ranks 55 among 239 journals (Q2) ranks 46 among 275 journals (Q1) ranks 99 among 333 journals (Q2)
2018 3.1 ranks 4 among 30 journals (Q2) ranks 12 among 27 journals (Q2) ranks 70 among 229 journals (Q2) ranks 58 among 262 journals (Q2) ranks 106 among 313 journals (Q2)
2017 3.2 NA NA ranks 57 among 226 journals (Q2) NA NA
2016 2.3 NA NA ranks 91 among 216 journals (Q2) NA NA

Abbreviations: NA, not available; Q1, quartile 1.

 

https://www.ijhpm.comdata/ijhpm/news/FullHtml/12/ijhpm-12-8124-g004
Figure 4. IJHPM Citation Trend in Web of Science and Scopus.

 

Table 5 highlights the top 10 most frequently cited articles published by the IJHPM in the past decade. Notably, the article titled “The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence”175 authored by Zachary Munn, Sandeep Moola, Dagmara Riitano, and Karolina Lisy in 2014 has received the highest number of citations overall is.

 

Table 5. IJHPM’s Top 10 Highly Cited Articles
Article Title Authors Document Type Times Cited* DOI
The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence Munn, Zachary; Moola, Sandeep; Riitano, Dagmara; Lisy, Karolina Original Article 637 10.15171/ijhpm.2014.71
Factors influencing healthcare service quality Mosadeghrad, Ali Mohammad Original Article 216 10.15171/ijhpm.2014.65
Unequal Gain of equal resources across racial groups Assari, Shervin Perspective 173 10.15171/ijhpm.2017.90
What is resilience and how can it be nurtured? a systematic review of empirical literature on organizational resilience Barasa, Edwine; Mbau, Rahab; Gilson, Lucy Review Article 170 10.15171/ijhpm.2018.06
Collaboration and co-production of knowledge in healthcare: opportunities and challenges Rycroft-Malone, Jo; Burton, Christopher R.; Bucknall, Tracey; Graham, Ian D.; Hutchinson, Alison M.; Stacey, Dawn Editorial 123 10.15171/ijhpm.2016.08
Governance and capacity to manage resilience of health systems: towards a new conceptual framework Blanchet, Karl; Nam, Sara L.; Ramalingam, Ben; Pozo-Martin, Francisco Perspective 121 10.15171/ijhpm.2017.36
Defining integrated knowledge translation and moving forward: a response to recent commentaries Kothari, Anita; McCutcheon, Chris; Graham, Ian D. Correspondence 112 10.15171/ijhpm.2017.15
Knowledge, moral claims and the exercise of power in global health Shiffman, Jeremy Editorial 112 10.15171/ijhpm.2014.120
Occupational stress and turnover intention: implications for nursing management Mosadeghrad, Ali Mohammad Original Article 104 10.15171/ijhpm.2013.30
Out-of-pocket payments, catastrophic health expenditure and poverty among households in Nigeria 2010 Aregbeshola, Bolaji Samson; Khan, Samina Mohsin Original Article 96 10.15171/ijhpm.2018.19

* This data was extracted from Web of Science on May 2023.

 

IJHPM Hosted an International Seminar

On April 19, 2014, the IJHPM team held an impactful international seminar focused on the theme of “improving quality and efficiency of health services by introducing market incentives, competition, and choice: opportunities and challenges” (Supplementary file 2). The seminar featured an esteemed keynote speaker, Marianna Fotaki who provided valuable insights and perspectives on the main theme of the seminar, and Dr. Alex Scott-Samuel, Professor Carol Molinari, Dr. Owen Adams, and Professor Ian Greener contributed to the seminar by sending pre-recorded videos. The event also witnessed the active participation of renowned Iranian scholars in the field, who attended in person and engaged in fruitful discussions, further enriching the seminar’s outcomes.

Conclusion

This editorial aimed to provide an assessment of the progress and evolution of the IJHPM over the past decade. Despite being a relatively new journal in the health policy and management field based in a resource-limited LMIC, the IJHPM has demonstrated remarkable growth in both quality and quantity measures. With its emphasis on timely high-quality publication and a commitment to fostering scholarly discourse, the IJHPM has become one of the leading and reputable journals for researchers in the health policy and management field. By implementing a culture that values quality, respect, fairness, inclusiveness, teamwork and collaboration, innovation, and speed, the journal has established itself as a valuable resource for academics, policymakers, and practitioners. These values permeate all IJHPM activities and we will keep them in focus while continuing to expand our capacity to meet the growing demands for high-quality publications. Moving forward, the IJHPM is poised to continue its upward trajectory and contribute to the advancement of health policy and management research. These achievements would have been impossible without the continuous and hard efforts of highly dedicated and committed IJHPM editorial office members, active and supportive editorial board members, dedicated reviewers, respected authors, and supportive loyal readers.

Acknowledgment

We thank the IJHPM office staff, particularly Hafez Mohammadhassanzadeh, Fatemeh Molaei, and Zeinab Golestanikhah, for their great assistance.

Ethical issues

Not applicable.

Competing interests

All authors are in-house editors at the IJHPM.

Endnotes

[1] Special Issue on Analysing the Politics of Health Policy Change in LMICs, July 2021; edited by Lucy Gilson, Zubin Cyrus Shroff, and Maylene Shung-King.

Special Issue on WHO-CHOICE Update, November 2021; edited by Melanie Y. Bertram, Tessa Tan Torres Edejer, and led by Mohammad Hajizadeh.

Special Issue on Political Economy of Food Systems, December 2021; edited by Phillip Baker, Jennifer Lacy-Nichols, Ronald Labonté, and Owain Williams.

Special Issue on CHS-Connect, January 2022; edited by Helen Schneider, Anna-Karin Hurtig, Joseph Zulu, Uta Lehmann, Miguel San Sebastian, and Charles Michelo.

[2] We have included here the invited-only articles (i.e., editorial, commentary, and correspondence articles). Without the invited-only articles, the acceptance rate is 9% [output date: May 21, 2023].

[3] On March 2021, Mendeley retired the public groups so the public page of IJHPM in Mendeley were removed (https://blog.mendeley.com/2020/11/02/weve-listened-to-our-users-and-are-refocusing-on-whats-important-to-them/); last access: May 21, 2023

Supplementary files

Supplementary file 1. IJHPM Editors Including in-house Editors, Editorial Board Members, and Staff Members.

Supplementary file 2. IJHPM International Seminar’s Agenda.

References

  1. Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev 2016; 1:2. doi: 10.1186/s41073-016-0007-6 [Crossref] [ Google Scholar]
  2. MEDLINE Data. https://www.ncbi.nlm.nih.gov/IEB/ToolBox/SDKDOCS/MEDLINE.HTML. Accessed May 2023.
  3. How to Include a Journal in MEDLINE. 2022. https://www.nlm.nih.gov/medline/medline_how_to_include.html#:~:text=The%20journal%20must%20have%20published,12%20months%20must%20contain%20abstracts. Accessed May 2023.
  4. Scopus: Content Policy and Selection. https://www.elsevier.com/solutions/scopus/how-scopus-works/content/content-policy-and-selection. May 2023.
  5. Web of Science Journal Evaluation Process and Selection Criteria. https://clarivate.com/products/scientific-and-academic-research/research-discovery-and-workflow-solutions/web-of-science/core-collection/editorial-selection-process/editorial-selection-process/. May 2023.
  6. Aryankhesal A. Strategic faults in implementation of hospital accreditation programs in developing countries: reflections on the Iranian experience. Int J Health Policy Manag 2016; 5(9):515-517. doi: 10.15171/ijhpm.2016.70 [Crossref] [ Google Scholar]
  7. Atwoli L, Baqui AH, Benfield T. Call for emergency action to limit global temperature increases, restore biodiversity, and protect health wealthy nations must do much more, much faster. Int J Health Policy Manag 2021; 10(10):602-604. doi: 10.34172/ijhpm.2021.108 [Crossref] [ Google Scholar]
  8. Atwoli L, Erhabor GE, Gbakima AA. COP27 climate change conference: urgent action needed for Africa and the world. Int J Health Policy Manag 2022; 11(10):1983-1985. doi: 10.34172/ijhpm.2022.7752 [Crossref] [ Google Scholar]
  9. Baker P, Lacy-Nichols J, Williams O, Labonté R. The political economy of healthy and sustainable food systems: an introduction to a special issue. Int J Health Policy Manag 2021; 10(12):734-744. doi: 10.34172/ijhpm.2021.156 [Crossref] [ Google Scholar]
  10. Baltussen R, Jansen MP, Mikkelsen E. Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness. Int J Health Policy Manag 2016; 5(11):615-618. doi: 10.15171/ijhpm.2016.83 [Crossref] [ Google Scholar]
  11. Baltussen R, Mitton C, Danis M, Williams I, Gold M. Global developments in priority setting in health. Int J Health Policy Manag 2017; 6(3):127-128. doi: 10.15171/ijhpm.2017.10 [Crossref] [ Google Scholar]
  12. Bertram MY, Edejer TTT. Introduction to the special Issue on “The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) update. ” Int J Health Policy Manag 2021; 10(11):670-672. doi: 10.34172/ijhpm.2021.105 [Crossref] [ Google Scholar]
  13. Binagwaho A. University of Global Health Equity’s contribution to the reduction of education and health services rationing. Int J Health Policy Manag 2017; 6(8):427-429. doi: 10.15171/ijhpm.2017.56 [Crossref] [ Google Scholar]
  14. Binagwaho A. We need compassionate leadership management based on evidence to defeat COVID-19. Int J Health Policy Manag 2020; 9(10):413-414. doi: 10.34172/ijhpm.2020.73 [Crossref] [ Google Scholar]
  15. Binagwaho A, Frisch MF, Udoh K. Implementation research: an efficient and effective tool to accelerate universal health coverage. Int J Health Policy Manag 2020; 9(5):182-184. doi: 10.15171/ijhpm.2019.125 [Crossref] [ Google Scholar]
  16. Binagwaho A, Mathewos K, Davis S. Equitable and effective distribution of the COVID-19 vaccines - a scientific and moral obligation. Int J Health Policy Manag 2022; 11(2):100-102. doi: 10.34172/ijhpm.2021.49 [Crossref] [ Google Scholar]
  17. Bradley EH. Diversity, inclusive leadership, and health outcomes. Int J Health Policy Manag 2020; 9(7):266-268. doi: 10.15171/ijhpm.2020.12 [Crossref] [ Google Scholar]
  18. Bradley EH, Taylor LA, Cuellar CJ. Management matters: a leverage point for health systems strengthening in global health. Int J Health Policy Manag 2015; 4(7):411-415. doi: 10.15171/ijhpm.2015.101 [Crossref] [ Google Scholar]
  19. Bruen C, Brugha R. A ghost in the machine? Politics in global health policy. Int J Health Policy Manag 2014; 3(1):1-4. doi: 10.15171/ijhpm.2014.59 [Crossref] [ Google Scholar]
  20. Brugha R, Crowe S. Relevance and effectiveness of the WHO Global Code Practice on the International Recruitment of Health Personnel--ethical and systems perspectives. Int J Health Policy Manag 2015; 4(6):333-336. doi: 10.15171/ijhpm.2015.103 [Crossref] [ Google Scholar]
  21. Burton CR, Rycroft-Malone J. Resource based view of the firm as a theoretical lens on the organisational consequences of quality improvement. Int J Health Policy Manag 2014; 3(3):113-115. doi: 10.15171/ijhpm.2014.74 [Crossref] [ Google Scholar]
  22. Carey G, Friel S. Understanding the role of public administration in implementing action on the social determinants of health and health inequities. Int J Health Policy Manag 2015; 4(12):795-798. doi: 10.15171/ijhpm.2015.185 [Crossref] [ Google Scholar]
  23. Churchill LR, Churchill SC. Buying health: the costs of commercialism and an alternative philosophy. Int J Health Policy Manag 2013; 1(2):91-93. doi: 10.15171/ijhpm.2013.14 [Crossref] [ Google Scholar]
  24. Daniels N, Porteny T, Urritia J. Expanded HTA: enhancing fairness and legitimacy. Int J Health Policy Manag 2015; 5(1):1-3. doi: 10.15171/ijhpm.2015.187 [Crossref] [ Google Scholar]
  25. El-Jardali F, Fadlallah R. A call for a backward design to knowledge translation. Int J Health Policy Manag 2015; 4(1):1-5. doi: 10.15171/ijhpm.2015.10 [Crossref] [ Google Scholar]
  26. Eyal N. Nudging by shaming, shaming by nudging. Int J Health Policy Manag 2014; 3(2):53-56. doi: 10.15171/ijhpm.2014.68 [Crossref] [ Google Scholar]
  27. Eyal N, Cancedda C, Kyamanywa P, Hurst SA. Non-physician clinicians in sub-Saharan Africa and the evolving role of physicians. Int J Health Policy Manag 2015; 5(3):149-153. doi: 10.15171/ijhpm.2015.215 [Crossref] [ Google Scholar]
  28. Forest PG. A new synthesis. Int J Health Policy Manag 2014; 2(2):55-57. doi: 10.15171/ijhpm.2014.13 [Crossref] [ Google Scholar]
  29. Forest PG, Denis JL, Brown LD, Helms D. Health reform requires policy capacity. Int J Health Policy Manag 2015; 4(5):265-266. doi: 10.15171/ijhpm.2015.85 [Crossref] [ Google Scholar]
  30. Forget EL. Paying people to be healthy. Int J Health Policy Manag 2013; 1(4):245-246. doi: 10.15171/ijhpm.2013.51 [Crossref] [ Google Scholar]
  31. Fotaki M. Why and how is compassion necessary to provide good quality healthcare?. Int J Health Policy Manag 2015; 4(4):199-201. doi: 10.15171/ijhpm.2015.66 [Crossref] [ Google Scholar]
  32. Fotaki M. A crisis of humanitarianism: refugees at the gates of Europe. Int J Health Policy Manag 2019; 8(6):321-324. doi: 10.15171/ijhpm.2019.22 [Crossref] [ Google Scholar]
  33. Friel S. Inequities in the freedom to lead a flourishing and healthy life: issues for healthy public policy. Int J Health Policy Manag 2014; 3(4):161-163. doi: 10.15171/ijhpm.2014.82 [Crossref] [ Google Scholar]
  34. Gajewski J, Bijlmakers L, Brugha R. Global surgery - informing national strategies for scaling up surgery in sub-Saharan Africa. Int J Health Policy Manag 2018; 7(6):481-484. doi: 10.15171/ijhpm.2018.27 [Crossref] [ Google Scholar]
  35. Gilson L, Shroff ZC, Shung-King M. Introduction to the special Issue on “Analysing the politics of health policy change in low- and middle-income countries: The HPA Fellowship Programme 2017-2019. ” Int J Health Policy Manag 2021; 10(7):360-363. doi: 10.34172/ijhpm.2021.43 [Crossref] [ Google Scholar]
  36. Goddard M. Competition in healthcare: good, bad or ugly?. Int J Health Policy Manag 2015; 4(9):567-569. doi: 10.15171/ijhpm.2015.144 [Crossref] [ Google Scholar]
  37. Goddard M, Mason AR. Integrated care: a pill for all ills?. Int J Health Policy Manag 2017; 6(1):1-3. doi: 10.15171/ijhpm.2016.111 [Crossref] [ Google Scholar]
  38. Gostin LO. The legal determinants of health: how can we achieve universal health coverage and what does it mean?. Int J Health Policy Manag 2021; 10(1):1-4. doi: 10.34172/ijhpm.2020.64 [Crossref] [ Google Scholar]
  39. Gusmano MK, Rodwin VG. Needed: global collaboration for comparative research on cities and health. Int J Health Policy Manag 2016; 5(7):399-401. doi: 10.15171/ijhpm.2016.39 [Crossref] [ Google Scholar]
  40. Haghdoost AA, Shahravan A. Do you recommend an interdisciplinary field to your graduate student?. Int J Health Policy Manag 2013; 1(1):1-2. doi: 10.15171/ijhpm.2013.01 [Crossref] [ Google Scholar]
  41. Hajizadeh M. Legalizing and regulating marijuana in Canada: review of potential economic, social, and health impacts. Int J Health Policy Manag 2016; 5(8):453-456. doi: 10.15171/ijhpm.2016.63 [Crossref] [ Google Scholar]
  42. Hajizadeh M, Edmonds S. Universal pharmacare in Canada: a prescription for equity in healthcare. Int J Health Policy Manag 2020; 9(3):91-95. doi: 10.15171/ijhpm.2019.93 [Crossref] [ Google Scholar]
  43. Harvey G. The many meanings of evidence: implications for the translational science agenda in healthcare. Int J Health Policy Manag 2013; 1(3):187-188. doi: 10.15171/ijhpm.2013.34 [Crossref] [ Google Scholar]
  44. Harvey G, Dollard J, Marshall A, Mittinty MM. Achieving integrated care for older people: shuffling the deckchairs or making the system watertight for the future?. Int J Health Policy Manag 2018; 7(4):290-293. doi: 10.15171/ijhpm.2017.144 [Crossref] [ Google Scholar]
  45. Harvey G, Kitson A. Translating evidence into healthcare policy and practice: single versus multi-faceted implementation strategies - is there a simple answer to a complex question?. Int J Health Policy Manag 2015; 4(3):123-126. doi: 10.15171/ijhpm.2015.54 [Crossref] [ Google Scholar]
  46. Hutchinson E, Balabanova D, McKee M. We need to talk about corruption in health systems. Int J Health Policy Manag 2019; 8(4):191-194. doi: 10.15171/ijhpm.2018.123 [Crossref] [ Google Scholar]
  47. Ikegami N. Fee-for-service payment - an evil practice that must be stamped out?. Int J Health Policy Manag 2015; 4(2):57-59. doi: 10.15171/ijhpm.2015.26 [Crossref] [ Google Scholar]
  48. Ikegami N. Achieving universal health coverage by focusing on primary care in Japan: lessons for low- and middle-income countries. Int J Health Policy Manag 2016; 5(5):291-293. doi: 10.15171/ijhpm.2016.22 [Crossref] [ Google Scholar]
  49. Ikegami N. Financing long-term care: lessons from Japan. Int J Health Policy Manag 2019; 8(8):462-466. doi: 10.15171/ijhpm.2019.35 [Crossref] [ Google Scholar]
  50. Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Improving the quality and quantity of HIV Data in the Middle East and North Africa: key challenges and ways forward. Int J Health Policy Manag 2017; 6(2):65-69. doi: 10.15171/ijhpm.2016.112 [Crossref] [ Google Scholar]
  51. Kickbusch I. Global health governance challenges 2016 - are we ready?. Int J Health Policy Manag 2016; 5(6):349-353. doi: 10.15171/ijhpm.2016.27 [Crossref] [ Google Scholar]
  52. Labonté R. Health promotion in an age of normative equity and rampant inequality. Int J Health Policy Manag 2016; 5(12):675-682. doi: 10.15171/ijhpm.2016.95 [Crossref] [ Google Scholar]
  53. Labonté R. Ensuring global health equity in a post-pandemic economy. Int J Health Policy Manag 2022; 11(8):1246-1250. doi: 10.34172/ijhpm.2022.7212 [Crossref] [ Google Scholar]
  54. Lunt N, Mannion R. Patient mobility in the global marketplace: a multidisciplinary perspective. Int J Health Policy Manag 2014; 2(4):155-157. doi: 10.15171/ijhpm.2014.47 [Crossref] [ Google Scholar]
  55. Luo Z, Fabre G, Rodwin VG. Meeting the challenge of diabetes in China. Int J Health Policy Manag 2020; 9(2):47-52. doi: 10.15171/ijhpm.2019.80 [Crossref] [ Google Scholar]
  56. Mannion R, Braithwaite J. False dawns and new horizons in patient safety research and practice. Int J Health Policy Manag 2017; 6(12):685-689. doi: 10.15171/ijhpm.2017.115 [Crossref] [ Google Scholar]
  57. Mannion R, Davies HT. Cultures of silence and cultures of voice: the role of whistleblowing in healthcare organisations. Int J Health Policy Manag 2015; 4(8):503-505. doi: 10.15171/ijhpm.2015.120 [Crossref] [ Google Scholar]
  58. Mannion R, Exworthy M. (Re) making the procrustean bed? Standardization and customization as competing logics in healthcare. Int J Health Policy Manag 2017; 6(6):301-304. doi: 10.15171/ijhpm.2017.35 [Crossref] [ Google Scholar]
  59. Mannion R, Small N. On folk devils, moral panics and new wave public health. Int J Health Policy Manag 2019; 8(12):678-683. doi: 10.15171/ijhpm.2019.78 [Crossref] [ Google Scholar]
  60. McDonald R. Leadership and leadership development in healthcare settings - a simplistic solution to complex problems?. Int J Health Policy Manag 2014; 3(5):227-229. doi: 10.15171/ijhpm.2014.101 [Crossref] [ Google Scholar]
  61. McKee M, Stuckler D. Reflective practice: how the World Bank explored its own biases?. Int J Health Policy Manag 2015; 5(2):79-82. doi: 10.15171/ijhpm.2015.216 [Crossref] [ Google Scholar]
  62. Mesgarpour B, Aghababa S, Baradaran HR. Achievements of the Cochrane Iran Associate Centre: lessons learned. Int J Health Policy Manag 2020; 9(6):222-228. doi: 10.15171/ijhpm.2019.122 [Crossref] [ Google Scholar]
  63. Mialon M, Fooks G, Cullerton K. Corporations and health: the need to combine forces to improve population health. Int J Health Policy Manag 2022; 11(7):871-873. doi: 10.34172/ijhpm.2022.6687 [Crossref] [ Google Scholar]
  64. Michelo C, Hurtig AK, Schneider H. Working towards inclusive, socially accountable and resilient community health systems: an introduction to a special issue. Int J Health Policy Manag 2022; 11(1):1-4. doi: 10.34172/ijhpm.2021.166 [Crossref] [ Google Scholar]
  65. Moradi-Lakeh M, Vosoogh-Moghaddam A. Health sector evolution plan in Iran; equity and sustainability concerns. Int J Health Policy Manag 2015; 4(10):637-640. doi: 10.15171/ijhpm.2015.160 [Crossref] [ Google Scholar]
  66. Norheim OF. A grand convergence in mortality is possible: Comment on Global health 2035. Int J Health Policy Manag 2014; 2(1):1-3. doi: 10.15171/ijhpm.2014.01 [Crossref] [ Google Scholar]
  67. Norheim OF. Ethical perspective: five unacceptable trade-offs on the path to universal health coverage. Int J Health Policy Manag 2015; 4(11):711-714. doi: 10.15171/ijhpm.2015.184 [Crossref] [ Google Scholar]
  68. Norheim OF. Disease control priorities third edition is published: a theory of change is needed for translating evidence to health policy. Int J Health Policy Manag 2018; 7(9):771-777. doi: 10.15171/ijhpm.2018.60 [Crossref] [ Google Scholar]
  69. Paton CR. The politics and analytics of health policy. Int J Health Policy Manag 2014; 2(3):105-107. doi: 10.15171/ijhpm.2014.26 [Crossref] [ Google Scholar]
  70. Powell M, Mannion R. Modelling the health policy process: one size fits all or horses for courses?. Int J Health Policy Manag 2023; 12:7580. doi: 10.34172/ijhpm.2022.7580 [Crossref] [ Google Scholar]
  71. Roache SA, Gostin LO. The untapped power of soda taxes: incentivizing consumers, generating revenue, and altering corporate behavior. Int J Health Policy Manag 2017; 6(9):489-493. doi: 10.15171/ijhpm.2017.69 [Crossref] [ Google Scholar]
  72. Rodwin VG, Fabre G, Ayoub RF. BRIC health systems and Big Pharma: a challenge for health policy and management. Int J Health Policy Manag 2018; 7(3):201-206. doi: 10.15171/ijhpm.2017.145 [Crossref] [ Google Scholar]
  73. Rycroft-Malone J, Burton CR, Bucknall T, Graham ID, Hutchinson AM, Stacey D. Collaboration and co-production of knowledge in healthcare: opportunities and challenges. Int J Health Policy Manag 2016; 5(4):221-223. doi: 10.15171/ijhpm.2016.08 [Crossref] [ Google Scholar]
  74. Shiffman J. Knowledge, moral claims and the exercise of power in global health. Int J Health Policy Manag 2014; 3(6):297-299. doi: 10.15171/ijhpm.2014.120 [Crossref] [ Google Scholar]
  75. Shiffman J. Four challenges that global health networks face. Int J Health Policy Manag 2017; 6(4):183-189. doi: 10.15171/ijhpm.2017.14 [Crossref] [ Google Scholar]
  76. Shiffman J. Agency, structure and the power of global health networks. Int J Health Policy Manag 2018; 7(10):879-884. doi: 10.15171/ijhpm.2018.71 [Crossref] [ Google Scholar]
  77. Speed E, Mannion R. The rise of post-truth populism in pluralist liberal democracies: challenges for health policy. Int J Health Policy Manag 2017; 6(5):249-251. doi: 10.15171/ijhpm.2017.19 [Crossref] [ Google Scholar]
  78. Takian A, Kazempour-Ardebili S. Diabetes dictating policy: an editorial commemorating world health day 2016. Int J Health Policy Manag 2016; 5(10):571-573. doi: 10.15171/ijhpm.2016.79 [Crossref] [ Google Scholar]
  79. Takian A, Mousavi A, McKee M. COP27: the prospects and challenges for the Middle East and North Africa (MENA). Int J Health Policy Manag 2022; 11(12):2776-2779. doi: 10.34172/ijhpm.2022.7800 [Crossref] [ Google Scholar]
  80. Tangcharoensathien V, Chandrasiri O, Kunpeuk W, Markchang K, Pangkariya N. Addressing NCDs: challenges from industry market promotion and interferences. Int J Health Policy Manag 2019; 8(5):256-260. doi: 10.15171/ijhpm.2019.02 [Crossref] [ Google Scholar]
  81. Tangcharoensathien V, Patcharanarumol W, Suwanwela W. Defining the benefit package of Thailand universal coverage scheme: from pragmatism to sophistication. Int J Health Policy Manag 2020; 9(4):133-137. doi: 10.15171/ijhpm.2019.96 [Crossref] [ Google Scholar]
  82. Tangcharoensathien V, Srisookwatana O, Pinprateep P, Posayanonda T, Patcharanarumol W. Multisectoral actions for health: challenges and opportunities in complex policy environments. Int J Health Policy Manag 2017; 6(7):359-363. doi: 10.15171/ijhpm.2017.61 [Crossref] [ Google Scholar]
  83. Yang Q, Dong H. Have health human resources become more equal between rural and urban areas after the new reform?. Int J Health Policy Manag 2014; 3(7):359-360. doi: 10.15171/ijhpm.2014.129 [Crossref] [ Google Scholar]
  84. Carmichael JL, Karamouzian M. Deadly professions: violent attacks against aid-workers and the health implications for local populations. Int J Health Policy Manag 2014; 2(2):65-67. doi: 10.15171/ijhpm.2014.16 [Crossref] [ Google Scholar]
  85. Hategekimana C, Karamouzian M. Self-perceived mental health status and uptake of fecal occult blood test for colorectal cancer screening in Canada: a cross-sectional study. Int J Health Policy Manag 2016; 5(6):365-371. doi: 10.15171/ijhpm.2016.14 [Crossref] [ Google Scholar]
  86. Hosseini Hooshyar S, Karamouzian M, Mirzazadeh A, Haghdoost AA, Sharifi H, Shokoohi M. Condom use and its associated factors among Iranian youth: results from a population-based study. Int J Health Policy Manag 2018; 7(11):1007-1014. doi: 10.15171/ijhpm.2018.65 [Crossref] [ Google Scholar]
  87. Karamouzian M. Trump’s zero-tolerance policy: would a political response to a humanitarian crisis work?. Int J Health Policy Manag 2018; 7(11):1070-1072. doi: 10.15171/ijhpm.2018.80 [Crossref] [ Google Scholar]
  88. Karamouzian M, Haghdoost AA, Sharifi H. Addressing the needs of sexual partners of people who inject drugs through peer prevention programs in Iran. Int J Health Policy Manag 2014; 2(2):81-83. doi: 10.15171/ijhpm.2014.19 [Crossref] [ Google Scholar]
  89. Karamouzian M, Hategekimana C. Ebola treatment and prevention are not the only battles: understanding Ebola-related fear and stigma. Int J Health Policy Manag 2015; 4(1):55-56. doi: 10.15171/ijhpm.2014.128 [Crossref] [ Google Scholar]
  90. Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Tackling HIV in MENA: talk is not Enough-It is time for bold actions: a response to recent commentaries. Int J Health Policy Manag 2018; 7(2):199-200. doi: 10.15171/ijhpm.2017.110 [Crossref] [ Google Scholar]
  91. Karamouzian M, Sharifi H, Haghdoost AA. Iran’s shift in family planning policies: concerns and challenges. Int J Health Policy Manag 2014; 3(5):231-233. doi: 10.15171/ijhpm.2014.81 [Crossref] [ Google Scholar]
  92. Nasirian M, Hosseini Hooshyar S, Haghdoost AA, Karamouzian M. How and where do we ask sensitive questions: self-reporting of STI-associated symptoms among the Iranian general population. Int J Health Policy Manag 2018; 7(8):738-745. doi: 10.15171/ijhpm.2018.18 [Crossref] [ Google Scholar]
  93. Nasirian M, Karamouzian M, Kamali K. Care seeking patterns of STIs-associated symptoms in Iran: findings of a population-based survey. Int J Health Policy Manag 2015; 5(1):5-11. doi: 10.15171/ijhpm.2015.146 [Crossref] [ Google Scholar]
  94. Nasirian M, Kianersi S, Karamouzian M. HIV modes of transmission in Sudan in 2014. Int J Health Policy Manag 2020; 9(3):108-115. doi: 10.15171/ijhpm.2019.91 [Crossref] [ Google Scholar]
  95. Rastegari A, Baneshi MR, Hajebi A. Population size estimation of people who use illicit drugs and alcohol in Iran (2015-2016). Int J Health Policy Manag 2022; 12:6578. doi: 10.34172/ijhpm.2022.6578 [Crossref] [ Google Scholar]
  96. Sharifi H, Jahani Y, Mirzazadeh A. Estimating COVID-19-Related infections, deaths, and hospitalizations in Iran under different physical distancing and isolation scenarios. Int J Health Policy Manag 2022; 11(3):334-343. doi: 10.34172/ijhpm.2020.134 [Crossref] [ Google Scholar]
  97. Sharifi H, Karamouzian M. Introducing ‘One Health’ as an overlooked concept in Iran. Int J Health Policy Manag 2014; 2(2):101-102. doi: 10.15171/ijhpm.2014.24 [Crossref] [ Google Scholar]
  98. Tavakoli F, Karamouzian M, Rafiei-Rad AA. HIV-related stigma among healthcare providers in different healthcare settings: a cross-sectional study in Kerman, Iran. Int J Health Policy Manag 2020; 9(4):163-169. doi: 10.15171/ijhpm.2019.92 [Crossref] [ Google Scholar]
  99. Vahidi M, Jalilian Khave L, Sanadgol G, Shirini D, Karamouzian M. Student-led initiatives’ potential in the COVID-19 response in Iran. Int J Health Policy Manag 2020; 9(10):464-465. doi: 10.34172/ijhpm.2020.82 [Crossref] [ Google Scholar]
  100. Mannion R. Enabling compassionate healthcare: perils, prospects and perspectives. Int J Health Policy Manag 2014; 2(3):115-117. doi: 10.15171/ijhpm.2014.34 [Crossref] [ Google Scholar]
  101. Sanderson J, Lonsdale C, Mannion R. Inside the black box: organisational buying behaviour and strategic purchasing in healthcare: a response to recent commentary. Int J Health Policy Manag 2019; 8(11):675-677. doi: 10.15171/ijhpm.2019.70 [Crossref] [ Google Scholar]
  102. Speed E, Mannion R. The politics and power of populism: a response to the recent commentaries. Int J Health Policy Manag 2018; 7(4):365-366. doi: 10.15171/ijhpm.2017.118 [Crossref] [ Google Scholar]
  103. Mannion R, Exworthy M. Researching the co-existence and continuity of standardization and customization in healthcare: a response to recent commentaries. Int J Health Policy Manag 2018; 7(6):572-573. doi: 10.15171/ijhpm.2018.07 [Crossref] [ Google Scholar]
  104. Mannion R. Take the money and run: the challenges of designing and evaluating financial incentives in healthcare: Comment on “Paying for performance in healthcare organisations. ” Int J Health Policy Manag 2014; 2(2):95-96. doi: 10.15171/ijhpm.2014.22 [Crossref] [ Google Scholar]
  105. Sanderson J, Lonsdale C, Mannion R. What’s needed to develop strategic purchasing in healthcare? Policy lessons from a realist review. Int J Health Policy Manag 2019; 8(1):4-17. doi: 10.15171/ijhpm.2018.93 [Crossref] [ Google Scholar]
  106. Mannion R, Braithwaite J. Where is patient safety research and practice heading? A response to recent commentaries. Int J Health Policy Manag 2019; 8(2):136-137. doi: 10.15171/ijhpm.2018.112 [Crossref] [ Google Scholar]
  107. Mannion R, Davies HT. Whistleblowing in the wind towards a socially situated research agenda: a response to recent commentaries. Int J Health Policy Manag 2016; 5(6):395-396. doi: 10.15171/ijhpm.2016.34 [Crossref] [ Google Scholar]
  108. Haghdoost AA, Ashrafi Asgar-Abad A, Shokoohi M, Alam M, Esmaeili M, Hojabri N. How do students conceptualise health and its risk factors? A study among Iranian schoolchildren. Int J Health Policy Manag 2013; 1(1):35-42. doi: 10.15171/ijhpm.2013.06 [Crossref] [ Google Scholar]
  109. Haji-Maghsoudi S, Haghdoost AA, Rastegari A, Baneshi MR. Influence of pattern of missing data on performance of imputation methods: an example using national data on drug injection in prisons. Int J Health Policy Manag 2013; 1(1):69-77. doi: 10.15171/ijhpm.2013.11 [Crossref] [ Google Scholar]
  110. Mohebbi E, Haghdoost AA, Noroozi A. Awareness and attitude towards opioid and stimulant use and lifetime prevalence of the drugs: a study in 5 large cities of Iran. Int J Health Policy Manag 2019; 8(4):222-232. doi: 10.15171/ijhpm.2018.128 [Crossref] [ Google Scholar]
  111. Nikfarjam A, Haji-Maghsoudi S, Rastegari A. The frequency of alcohol use in Iranian urban population: the results of a national network scale up survey. Int J Health Policy Manag 2017; 6(2):97-102. doi: 10.15171/ijhpm.2016.103 [Crossref] [ Google Scholar]
  112. Noori A, Shokoohi M, Baneshi MR, Naderi N, Bakhshandeh H, Haghdoost AA. Impact of socio-economic status on the hospital readmission of congestive heart failure patients: a prospective cohort study. Int J Health Policy Manag 2014; 3(5):251-257. doi: 10.15171/ijhpm.2014.94 [Crossref] [ Google Scholar]
  113. Labonté R. Framing political change: can a left populism disrupt the rise of the reactionary right? Comment on “Politics, power, poverty and global health: systems and frames. ” Int J Health Policy Manag 2017; 6(9):547-549. doi: 10.15171/ijhpm.2017.08 [Crossref] [ Google Scholar]
  114. Labonté R. From mid-level policy analysis to macro-level political economy: Comment on “Developing a framework for a program theory-based approach to evaluating policy processes and outcomes: health in all policies in South Australia. ” Int J Health Policy Manag 2018; 7(7):656-658. doi: 10.15171/ijhpm.2018.12 [Crossref] [ Google Scholar]
  115. Labonté R. From the myth of level playing fields to the reality of a finite planet: Comment on “A global social support system: what the international community could learn from the United States’ National Basketball Association’s scheme for redistribution of new talent. ” Int J Health Policy Manag 2015; 5(2):137-139. doi: 10.15171/ijhpm.2015.202 [Crossref] [ Google Scholar]
  116. Bergen N, Ruckert A, Labonté R. Monitoring frameworks for universal health coverage: what about high-income countries?. Int J Health Policy Manag 2019; 8(7):387-393. doi: 10.15171/ijhpm.2019.21 [Crossref] [ Google Scholar]
  117. Labonté R. Neoliberalism 4.0: the rise of illiberal capitalism: Comment on “How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention.”. Int J Health Policy Manag 2020; 9(4):175-178. doi: 10.15171/ijhpm.2019.111 [Crossref] [ Google Scholar]
  118. Labonté R. Purveyors of the commercial determinants of health have no place at any policy table: Comment on “Towards preventing and managing conflict of interest in nutrition policy? An analysis of submissions to a consultation on a draft WHO tool. ” Int J Health Policy Manag 2022; 11(2):243-245. doi: 10.34172/ijhpm.2020.171 [Crossref] [ Google Scholar]
  119. Labonté R, Baum F. Right wing politics and public policy: the need for a broad frame and further research: Comment on “A scoping review of populist radical right parties’ influence on welfare policy and its implications for population health in Europe. ” Int J Health Policy Manag 2021; 10(8):519-522. doi: 10.34172/ijhpm.2020.137 [Crossref] [ Google Scholar]
  120. Labonté R, Schram A, Ruckert A. The TPP is dead, long live the TPP? A response to recent commentaries. Int J Health Policy Manag 2017; 6(4):245-247. doi: 10.15171/ijhpm.2017.12 [Crossref] [ Google Scholar]
  121. Labonté R, Schram A, Ruckert A. The Trans-Pacific Partnership: is it everything we feared for health?. Int J Health Policy Manag 2016; 5(8):487-496. doi: 10.15171/ijhpm.2016.41 [Crossref] [ Google Scholar]
  122. Townsend B, Friel S, Schram A, Baum F, Labonté R. What generates attention to health in trade policy-making? Lessons from success in tobacco control and access to medicines: a qualitative study of Australia and the (comprehensive and progressive) Trans-Pacific Partnership. Int J Health Policy Manag 2021; 10(10):613-624. doi: 10.34172/ijhpm.2020.80 [Crossref] [ Google Scholar]
  123. McKee M, Gugushvili A, Koltai J, Stuckler D. Are populist leaders creating the conditions for the spread of COVID-19? Comment on “A scoping review of populist radical right parties’ influence on welfare policy and its implications for population health in Europe. ” Int J Health Policy Manag 2021; 10(8):511-515. doi: 10.34172/ijhpm.2020.124 [Crossref] [ Google Scholar]
  124. Hutchinson E, Balabanova D, McKee M. Beyond talking: we need effective measures to tackle systemic corruption and the power that allows it to persist in health systems; a response to recent commentaries. Int J Health Policy Manag 2020; 9(12):536-538. doi: 10.15171/ijhpm.2020.21 [Crossref] [ Google Scholar]
  125. McKee M. Bridging the gap between research and policy and practice comment on “CIHR health system impact fellows: reflections on ‘driving change’ within the health system. ” Int J Health Policy Manag 2019; 8(9):557-559. doi: 10.15171/ijhpm.2019.46 [Crossref] [ Google Scholar]
  126. McKee M, Wouters OJ. The challenges of regulating artificial intelligence in healthcare: Comment on “Clinical decision support and new regulatory frameworks for medical devices: are we ready for it? - A viewpoint paper.” Int J Health Policy Manag 2022;12. 10.34172/ijhpm.2022.7261.
  127. McKee M, Stuckler D. “Enemies of the people?” Public health in the era of populist politics: Comment on “The rise of post-truth populism in pluralist liberal democracies: challenges for health policy. ” Int J Health Policy Manag 2017; 6(11):669-672. doi: 10.15171/ijhpm.2017.46 [Crossref] [ Google Scholar]
  128. Morris M, Seguin M, Landon S, McKee M, Nolte E. Exploring the role of leadership in facilitating change to improve cancer survival: an analysis of experiences in seven high income countries in the International Cancer Benchmarking Partnership (ICBP). Int J Health Policy Manag 2021; 11(9):1756-1766. doi: 10.34172/ijhpm.2021.84 [Crossref] [ Google Scholar]
  129. Abba-Aji M, Balabanova D, Hutchinson E, McKee M. How do Nigerian newspapers report corruption in the health system?. Int J Health Policy Manag 2021; 10(2):77-85. doi: 10.34172/ijhpm.2020.37 [Crossref] [ Google Scholar]
  130. Brathwaite R, Hutchinson E, McKee M, Palafox B, Balabanova D. The long and winding road: a systematic literature review conceptualising pathways for hypertension care and control in low- and middle-income countries. Int J Health Policy Manag 2022; 11(3):257-268. doi: 10.34172/ijhpm.2020.105 [Crossref] [ Google Scholar]
  131. Binyaruka P, Andreoni A, Balabanova D, McKee M, Hutchinson E, Angell B. Re-aligning incentives to address informal payments in Tanzania public health facilities: a discrete choice experiment. Int J Health Policy Manag 2023; 12:6877. doi: 10.34172/ijhpm.2022.6877 [Crossref] [ Google Scholar]
  132. Paltiel O, Hailu W, Abay Z, Clarfield AM, McKee M. “Sell an Ox” - the price of cure for hepatitis C in two countries. Int J Health Policy Manag 2020; 9(6):229-232. doi: 10.15171/ijhpm.2019.135 [Crossref] [ Google Scholar]
  133. Seguin M, Morris M, McKee M, Nolte E. “There’s not enough bodies to do the demand:” an exploration of key stakeholder views on the role of health service capacity in shaping cancer outcomes in 7 International Cancer Benchmarking Partnership countries. Int J Health Policy Manag 2020; 11(7):1024-1034. doi: 10.34172/ijhpm.2020.254 [Crossref] [ Google Scholar]
  134. Onwujekwe O, Orjiakor CT, Hutchinson E. Where do we start? Building consensus on drivers of health sector corruption in Nigeria and ways to address it. Int J Health Policy Manag 2020; 9(7):286-296. doi: 10.15171/ijhpm.2019.128 [Crossref] [ Google Scholar]
  135. Jeurissen PP, Maarse H. New provider models for Sweden and Spain: public, private or non-profit? Comment on “Governance, government, and the search for new provider models. ” Int J Health Policy Manag 2016; 5(12):721-723. doi: 10.15171/ijhpm.2016.87 [Crossref] [ Google Scholar]
  136. van der Wees PJ, Wammes JJ, Westert GP, Jeurissen PP. The relationship between the scope of essential health benefits and statutory financing: an international comparison across eight European countries. Int J Health Policy Manag 2015; 5(1):13-22. doi: 10.15171/ijhpm.2015.166 [Crossref] [ Google Scholar]
  137. van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Medicalisation and overdiagnosis: what society does to medicine. Int J Health Policy Manag 2016; 5(11):619-622. doi: 10.15171/ijhpm.2016.121 [Crossref] [ Google Scholar]
  138. Mosca I, van der Wees PJ, Mot ES, Wammes JJG, Jeurissen PP. Sustainability of long-term care: puzzling tasks ahead for policy-makers. Int J Health Policy Manag 2017; 6(4):195-205. doi: 10.15171/ijhpm.2016.109 [Crossref] [ Google Scholar]
  139. van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Define and conquer: how semantics foster progress; a response to recent commentaries. Int J Health Policy Manag 2017; 6(11):681-682. doi: 10.15171/ijhpm.2017.116 [Crossref] [ Google Scholar]
  140. Auener S, Kroon D, Wackers E, van Dulmen S, Jeurissen PP. COVID-19: a window of opportunity for positive healthcare reforms. Int J Health Policy Manag 2020; 9(10):419-422. doi: 10.34172/ijhpm.2020.66 [Crossref] [ Google Scholar]
  141. Kruse FM, Jeurissen PP. For-profit hospitals out of business? Financial sustainability during the COVID-19 epidemic emergency response. Int J Health Policy Manag 2020; 9(10):423-428. doi: 10.34172/ijhpm.2020.67 [Crossref] [ Google Scholar]
  142. Tulp AD, Kruse FM, Stadhouders NW, Jeurissen PP. Independent treatment centres are not a guarantee for high quality and low healthcare prices in the Netherlands - a study of 5 elective surgeries. Int J Health Policy Manag 2020; 9(9):380-389. doi: 10.15171/ijhpm.2019.144 [Crossref] [ Google Scholar]
  143. van Dijk W, Meinders MJ, Tanke MA, Westert GP, Jeurissen PP. Medicalization defined in empirical contexts - a scoping review. Int J Health Policy Manag 2020; 9(8):327-334. doi: 10.15171/ijhpm.2019.101 [Crossref] [ Google Scholar]
  144. Jeurissen PP, Klazinga N, Hagenaars L. Complex governance does increase both the real and perceived registration burden: the case of the Netherlands: Comment on “Perceived burden due to registrations for quality monitoring and improvement in hospitals: a mixed methods study. ” Int J Health Policy Manag 2022; 11(4):533-535. doi: 10.34172/ijhpm.2020.264 [Crossref] [ Google Scholar]
  145. Vlaanderen FP, de Man Y, Tanke MA. Density of patient-sharing networks: impact on the value of Parkinson care. Int J Health Policy Manag 2021; 11(7):1132-1139. doi: 10.34172/ijhpm.2021.15 [Crossref] [ Google Scholar]
  146. Wackers E, Stadhouders N, Heil A, Westert G, van Dulmen S, Jeurissen P. Hospitals bending the cost curve with increased quality: a scoping review into integrated hospital strategies. Int J Health Policy Manag 2021; 11(11):2381-2391. doi: 10.34172/ijhpm.2021.168 [Crossref] [ Google Scholar]
  147. Jansen MP, Baltussen R, Mikkelsen E. Evidence-informed deliberative processes - early dialogue, broad focus and relevance: a response to recent commentaries. Int J Health Policy Manag 2018; 7(1):96-97. doi: 10.15171/ijhpm.2017.88 [Crossref] [ Google Scholar]
  148. Gajewski J, Brugha R, Bijlmakers L. Global surgery priorities: a response to recent commentaries. Int J Health Policy Manag 2019; 8(6):381-383. doi: 10.15171/ijhpm.2019.10 [Crossref] [ Google Scholar]
  149. Bijlmakers L. Systems science and evidence-informed deliberation to mitigate dilemmas in situations of dual agency at the hospital level: Comment on “Dual agency in hospitals: what strategies do managers and physicians apply to reconcile dilemmas between clinical and economic considerations. ” Int J Health Policy Manag 2022; 11(10):2337-2339. doi: 10.34172/ijhpm.2022.6940 [Crossref] [ Google Scholar]
  150. Broekhuizen H, Ifeanyichi M, Mwapasa G. Improving access to surgery through surgical team mentoring - policy lessons from group model building with local stakeholders in Malawi. Int J Health Policy Manag 2021; 11(9):1744-1755. doi: 10.34172/ijhpm.2021.78 [Crossref] [ Google Scholar]
  151. Broekhuizen H, Lansu M, Gajewski J. Using group model building to capture the complex dynamics of scaling up district-level surgery in Arusha region, Tanzania. Int J Health Policy Manag 2020; 11(7):981-989. doi: 10.34172/ijhpm.2020.249 [Crossref] [ Google Scholar]
  152. Gajewski J, Wallace M, Pittalis C. Why do they leave? Challenges to retention of surgical clinical officers in district hospitals in Malawi. Int J Health Policy Manag 2022; 11(3):354-361. doi: 10.34172/ijhpm.2020.142 [Crossref] [ Google Scholar]
  153. Ifeanyichi M, Broekhuizen H, Juma A. Economic costs of providing district- and regional-level surgeries in Tanzania. Int J Health Policy Manag 2021; 11(7):1120-1131. doi: 10.34172/ijhpm.2021.09 [Crossref] [ Google Scholar]
  154. Jansen M, Baltussen R, Bijlmakers L, Tummers M. The Dutch Citizen Forum on public reimbursement of healthcare: a qualitative analysis of opinion change. Int J Health Policy Manag 2022; 11(2):118-127. doi: 10.34172/ijhpm.2020.81 [Crossref] [ Google Scholar]
  155. Nouhi M, Baltussen R, Razavi SS. The use of evidence-informed deliberative processes for health insurance benefit package revision in Iran. Int J Health Policy Manag 2022; 11(11):2719-2726. doi: 10.34172/ijhpm.2022.6485 [Crossref] [ Google Scholar]
  156. Pittalis C, Brugha R, Bijlmakers L. Using network and complexity theories to understand the functionality of referral systems for surgical patients in resource-limited settings, the case of Malawi. Int J Health Policy Manag 2021; 11(11):2502-2513. doi: 10.34172/ijhpm.2021.175 [Crossref] [ Google Scholar]
  157. Brugha R, Bruen C. Politics matters: a response to recent commentaries. Int J Health Policy Manag 2014; 3(3):157-158. doi: 10.15171/ijhpm.2014.80 [Crossref] [ Google Scholar]
  158. Brugha R, Clarke N, Hendrick L, Sweeney J. Doctor retention: a cross-sectional study of how Ireland has been losing the battle. Int J Health Policy Manag 2021; 10(6):299-309. doi: 10.34172/ijhpm.2020.54 [Crossref] [ Google Scholar]
  159. Brugha R. Doctor retention in a COVID-world: an opportunity to reconfigure the health workforce, or “Plus ça change plus c’est la meme chose”? A response to the recent commentaries. Int J Health Policy Manag 2022; 11(6):865-868. doi: 10.34172/ijhpm.2021.60 [Crossref] [ Google Scholar]
  160. Baum F, Anaf J. A world beyond transnational corporations: meeting human rather than corporate need: Comment on “’Part of the solution’: food corporation strategies for regulatory capture and legitimacy. ” Int J Health Policy Manag 2022; 11(11):2748-2751. doi: 10.34172/ijhpm.2022.7540 [Crossref] [ Google Scholar]
  161. Baum F, Freeman T. Why community health systems have not flourished in high income countries: what the australian experience tells us. Int J Health Policy Manag 2022; 11(1):49-58. doi: 10.34172/ijhpm.2021.42 [Crossref] [ Google Scholar]
  162. Baum F, Townsend B, Fisher M. Creating political will for action on health equity: practical lessons for public health policy actors. Int J Health Policy Manag 2020; 11(7):947-960. doi: 10.34172/ijhpm.2020.233 [Crossref] [ Google Scholar]
  163. Fisher M, Freeman T, Mackean T, Friel S, Baum F. Universal health coverage for health equity: from principle to practice; a response to the recent commentaries. Int J Health Policy Manag 2022; 11(8):1601-1603. doi: 10.34172/ijhpm.2022.7218 [Crossref] [ Google Scholar]
  164. Fisher M, Freeman T, Mackean T, Friel S, Baum F. Universal health coverage for non-communicable diseases and health equity: lessons from Australian primary healthcare. Int J Health Policy Manag 2022; 11(5):690-700. doi: 10.34172/ijhpm.2020.232 [Crossref] [ Google Scholar]
  165. Fisher M, Harris P, Freeman T. Implementing universal and targeted policies for health equity: lessons from Australia. Int J Health Policy Manag 2021; 11(10):2308-2318. doi: 10.34172/ijhpm.2021.157 [Crossref] [ Google Scholar]
  166. Javanparast S, Baum F, Ziersch A, Freeman T. A framework to determine the extent to which regional primary healthcare organisations are comprehensive or selective in their approach. Int J Health Policy Manag 2022; 11(4):479-488. doi: 10.34172/ijhpm.2020.182 [Crossref] [ Google Scholar]
  167. Mateos JT, Fernández-Sáez J, Marcos-Marcos J. Gender equality and the global gender gap in life expectancy: an exploratory analysis of 152 countries. Int J Health Policy Manag 2022; 11(6):740-746. doi: 10.34172/ijhpm.2020.192 [Crossref] [ Google Scholar]
  168. Baum F, McGreevy MP, MacDougall CM, Henley M. Energy as a social and commercial determinant of health: a qualitative study of Australian policy. Int J Health Policy Manag 2023; 12:7193. doi: 10.34172/ijhpm.2022.7193 [Crossref] [ Google Scholar]
  169. Jansen MP, Helderman JK, Boer B, Baltussen R. Fair processes for priority setting: putting theory into practice: Comment on “Expanded HTA: enhancing fairness and legitimacy. ” Int J Health Policy Manag 2017; 6(1):43-47. doi: 10.15171/ijhpm.2016.85 [Crossref] [ Google Scholar]
  170. Seixas BV, Mitton C, Danis M, Williams I, Gold M, Baltussen R. Should priority setting also be concerned about profound socio-economic transformations? A response to recent commentary. Int J Health Policy Manag 2017; 6(12):733-734. doi: 10.15171/ijhpm.2017.85 [Crossref] [ Google Scholar]
  171. Jansen MP, Baltussen R, Bærøe K. Stakeholder participation for legitimate priority setting: a checklist. Int J Health Policy Manag 2018; 7(11):973-976. doi: 10.15171/ijhpm.2018.57 [Crossref] [ Google Scholar]
  172. Oortwijn W, Jansen M, Baltussen R. Use of evidence-informed deliberative processes by health technology assessment agencies around the globe. Int J Health Policy Manag 2020; 9(1):27-33. doi: 10.15171/ijhpm.2019.72 [Crossref] [ Google Scholar]
  173. Baltussen R, Jansen M, Oortwijn W. Evidence-informed deliberative processes for legitimate health benefit package design - part I: conceptual framework. Int J Health Policy Manag 2021; 11(10):2319-2326. doi: 10.34172/ijhpm.2021.158 [Crossref] [ Google Scholar]
  174. Oortwijn W, Jansen M, Baltussen R. Evidence-informed deliberative processes for health benefit package design - part II: a practical guide. Int J Health Policy Manag 2021; 11(10):2327-2336. doi: 10.34172/ijhpm.2021.159 [Crossref] [ Google Scholar]
  175. Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014; 3(3):123-128. doi: 10.15171/ijhpm.2014.71 [Crossref] [ Google Scholar]

References

  1. Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev 2016; 1:2. doi: 10.1186/s41073-016-0007-6 [Crossref] [Google Scholar]
  2. MEDLINE Data. https://www.ncbi.nlm.nih.gov/IEB/ToolBox/SDKDOCS/MEDLINE.HTML. Accessed May 2023.
  3. How to Include a Journal in MEDLINE. 2022. https://www.nlm.nih.gov/medline/medline_how_to_include.html#:~:text=The%20journal%20must%20have%20published,12%20months%20must%20contain%20abstracts. Accessed May 2023.
  4. Scopus: Content Policy and Selection. https://www.elsevier.com/solutions/scopus/how-scopus-works/content/content-policy-and-selection. May 2023.
  5. Web of Science Journal Evaluation Process and Selection Criteria. https://clarivate.com/products/scientific-and-academic-research/research-discovery-and-workflow-solutions/web-of-science/core-collection/editorial-selection-process/editorial-selection-process/. May 2023.
  6. Aryankhesal A. Strategic faults in implementation of hospital accreditation programs in developing countries: reflections on the Iranian experience. Int J Health Policy Manag 2016; 5(9):515-517. doi: 10.15171/ijhpm.2016.70 [Crossref] [ Google Scholar]
  7. Atwoli L, Baqui AH, Benfield T. Call for emergency action to limit global temperature increases, restore biodiversity, and protect health wealthy nations must do much more, much faster. Int J Health Policy Manag 2021; 10(10):602-604. doi: 10.34172/ijhpm.2021.108 [Crossref] [ Google Scholar]
  8. Atwoli L, Erhabor GE, Gbakima AA. COP27 climate change conference: urgent action needed for Africa and the world. Int J Health Policy Manag 2022; 11(10):1983-1985. doi: 10.34172/ijhpm.2022.7752 [Crossref] [ Google Scholar]
  9. Baker P, Lacy-Nichols J, Williams O, Labonté R. The political economy of healthy and sustainable food systems: an introduction to a special issue. Int J Health Policy Manag 2021; 10(12):734-744. doi: 10.34172/ijhpm.2021.156 [Crossref] [ Google Scholar]
  10. Baltussen R, Jansen MP, Mikkelsen E. Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness. Int J Health Policy Manag 2016; 5(11):615-618. doi: 10.15171/ijhpm.2016.83 [Crossref] [ Google Scholar]
  11. Baltussen R, Mitton C, Danis M, Williams I, Gold M. Global developments in priority setting in health. Int J Health Policy Manag 2017; 6(3):127-128. doi: 10.15171/ijhpm.2017.10 [Crossref] [ Google Scholar]
  12. Bertram MY, Edejer TTT. Introduction to the special Issue on “The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) update. ” Int J Health Policy Manag 2021; 10(11):670-672. doi: 10.34172/ijhpm.2021.105 [Crossref] [ Google Scholar]
  13. Binagwaho A. University of Global Health Equity’s contribution to the reduction of education and health services rationing. Int J Health Policy Manag 2017; 6(8):427-429. doi: 10.15171/ijhpm.2017.56 [Crossref] [ Google Scholar]
  14. Binagwaho A. We need compassionate leadership management based on evidence to defeat COVID-19. Int J Health Policy Manag 2020; 9(10):413-414. doi: 10.34172/ijhpm.2020.73 [Crossref] [ Google Scholar]
  15. Binagwaho A, Frisch MF, Udoh K. Implementation research: an efficient and effective tool to accelerate universal health coverage. Int J Health Policy Manag 2020; 9(5):182-184. doi: 10.15171/ijhpm.2019.125 [Crossref] [ Google Scholar]
  16. Binagwaho A, Mathewos K, Davis S. Equitable and effective distribution of the COVID-19 vaccines - a scientific and moral obligation. Int J Health Policy Manag 2022; 11(2):100-102. doi: 10.34172/ijhpm.2021.49 [Crossref] [Google Scholar]
  17. Bradley EH. Diversity, inclusive leadership, and health outcomes. Int J Health Policy Manag 2020; 9(7):266-268. doi: 10.15171/ijhpm.2020.12 [Crossref] [ Google Scholar]
  18. Bradley EH, Taylor LA, Cuellar CJ. Management matters: a leverage point for health systems strengthening in global health. Int J Health Policy Manag 2015; 4(7):411-415. doi: 10.15171/ijhpm.2015.101 [Crossref] [ Google Scholar]
  19. Bruen C, Brugha R. A ghost in the machine? Politics in global health policy. Int J Health Policy Manag 2014; 3(1):1-4. doi: 10.15171/ijhpm.2014.59 [Crossref] [ Google Scholar]
  20. Brugha R, Crowe S. Relevance and effectiveness of the WHO Global Code Practice on the International Recruitment of Health Personnel--ethical and systems perspectives. Int J Health Policy Manag 2015; 4(6):333-336. doi: 10.15171/ijhpm.2015.103 [Crossref] [ Google Scholar]
  21. Burton CR, Rycroft-Malone J. Resource based view of the firm as a theoretical lens on the organisational consequences of quality improvement. Int J Health Policy Manag 2014; 3(3):113-115. doi: 10.15171/ijhpm.2014.74 [Crossref] [ Google Scholar]
  22. Carey G, Friel S. Understanding the role of public administration in implementing action on the social determinants of health and health inequities. Int J Health Policy Manag 2015; 4(12):795-798. doi: 10.15171/ijhpm.2015.185 [Crossref] [ Google Scholar]
  23. Churchill LR, Churchill SC. Buying health: the costs of commercialism and an alternative philosophy. Int J Health Policy Manag 2013; 1(2):91-93. doi: 10.15171/ijhpm.2013.14 [Crossref] [ Google Scholar]
  24. Daniels N, Porteny T, Urritia J. Expanded HTA: enhancing fairness and legitimacy. Int J Health Policy Manag 2015; 5(1):1-3. doi: 10.15171/ijhpm.2015.187 [Crossref] [ Google Scholar]
  25. El-Jardali F, Fadlallah R. A call for a backward design to knowledge translation. Int J Health Policy Manag 2015; 4(1):1-5. doi: 10.15171/ijhpm.2015.10 [Crossref] [ Google Scholar]
  26. Eyal N. Nudging by shaming, shaming by nudging. Int J Health Policy Manag 2014; 3(2):53-56. doi: 10.15171/ijhpm.2014.68 [Crossref] [ Google Scholar]
  27. Eyal N, Cancedda C, Kyamanywa P, Hurst SA. Non-physician clinicians in sub-Saharan Africa and the evolving role of physicians. Int J Health Policy Manag 2015; 5(3):149-153. doi: 10.15171/ijhpm.2015.215 [Crossref] [ Google Scholar]
  28. Forest PG. A new synthesis. Int J Health Policy Manag 2014; 2(2):55-57. doi: 10.15171/ijhpm.2014.13 [Crossref] [Google Scholar]
  29. Forest PG, Denis JL, Brown LD, Helms D. Health reform requires policy capacity. Int J Health Policy Manag 2015; 4(5):265-266. doi: 10.15171/ijhpm.2015.85 [Crossref] [ Google Scholar]
  30. Forget EL. Paying people to be healthy. Int J Health Policy Manag 2013; 1(4):245-246. doi: 10.15171/ijhpm.2013.51 [Crossref] [ Google Scholar]
  31. Fotaki M. Why and how is compassion necessary to provide good quality healthcare?. Int J Health Policy Manag2015; 4(4):199-201. doi: 10.15171/ijhpm.2015.66 [Crossref] [ Google Scholar]
  32. Fotaki M. A crisis of humanitarianism: refugees at the gates of Europe. Int J Health Policy Manag 2019; 8(6):321-324. doi: 10.15171/ijhpm.2019.22 [Crossref] [ Google Scholar]
  33. Friel S. Inequities in the freedom to lead a flourishing and healthy life: issues for healthy public policy. Int J Health Policy Manag 2014; 3(4):161-163. doi: 10.15171/ijhpm.2014.82 [Crossref] [ Google Scholar]
  34. Gajewski J, Bijlmakers L, Brugha R. Global surgery - informing national strategies for scaling up surgery in sub-Saharan Africa. Int J Health Policy Manag 2018; 7(6):481-484. doi: 10.15171/ijhpm.2018.27 [Crossref] [ Google Scholar]
  35. Gilson L, Shroff ZC, Shung-King M. Introduction to the special Issue on “Analysing the politics of health policy change in low- and middle-income countries: The HPA Fellowship Programme 2017-2019. ” Int J Health Policy Manag 2021; 10(7):360-363. doi: 10.34172/ijhpm.2021.43 [Crossref] [ Google Scholar]
  36. Goddard M. Competition in healthcare: good, bad or ugly?. Int J Health Policy Manag 2015; 4(9):567-569. doi: 10.15171/ijhpm.2015.144 [Crossref] [ Google Scholar]
  37. Goddard M, Mason AR. Integrated care: a pill for all ills?. Int J Health Policy Manag 2017; 6(1):1-3. doi: 10.15171/ijhpm.2016.111 [Crossref] [ Google Scholar]
  38. Gostin LO. The legal determinants of health: how can we achieve universal health coverage and what does it mean?. Int J Health Policy Manag 2021; 10(1):1-4. doi: 10.34172/ijhpm.2020.64 [Crossref] [ Google Scholar]
  39. Gusmano MK, Rodwin VG. Needed: global collaboration for comparative research on cities and health. Int J Health Policy Manag 2016; 5(7):399-401. doi: 10.15171/ijhpm.2016.39 [Crossref] [ Google Scholar]
  40. Haghdoost AA, Shahravan A. Do you recommend an interdisciplinary field to your graduate student?. Int J Health Policy Manag 2013; 1(1):1-2. doi: 10.15171/ijhpm.2013.01 [Crossref] [ Google Scholar]
  41. Hajizadeh M. Legalizing and regulating marijuana in Canada: review of potential economic, social, and health impacts. Int J Health Policy Manag 2016; 5(8):453-456. doi: 10.15171/ijhpm.2016.63 [Crossref] [ Google Scholar]
  42. Hajizadeh M, Edmonds S. Universal pharmacare in Canada: a prescription for equity in healthcare. Int J Health Policy Manag 2020; 9(3):91-95. doi: 10.15171/ijhpm.2019.93 [Crossref] [ Google Scholar]
  43. Harvey G. The many meanings of evidence: implications for the translational science agenda in healthcare. Int J Health Policy Manag 2013; 1(3):187-188. doi: 10.15171/ijhpm.2013.34 [Crossref] [ Google Scholar]
  44. Harvey G, Dollard J, Marshall A, Mittinty MM. Achieving integrated care for older people: shuffling the deckchairs or making the system watertight for the future?. Int J Health Policy Manag 2018; 7(4):290-293. doi: 10.15171/ijhpm.2017.144 [Crossref] [ Google Scholar]
  45. Harvey G, Kitson A. Translating evidence into healthcare policy and practice: single versus multi-faceted implementation strategies - is there a simple answer to a complex question?. Int J Health Policy Manag 2015; 4(3):123-126. doi: 10.15171/ijhpm.2015.54 [Crossref] [ Google Scholar]
  46. Hutchinson E, Balabanova D, McKee M. We need to talk about corruption in health systems. Int J Health Policy Manag 2019; 8(4):191-194. doi: 10.15171/ijhpm.2018.123 [Crossref] [ Google Scholar]
  47. Ikegami N. Fee-for-service payment - an evil practice that must be stamped out?. Int J Health Policy Manag 2015; 4(2):57-59. doi: 10.15171/ijhpm.2015.26 [Crossref] [ Google Scholar]
  48. Ikegami N. Achieving universal health coverage by focusing on primary care in Japan: lessons for low- and middle-income countries. Int J Health Policy Manag 2016; 5(5):291-293. doi: 10.15171/ijhpm.2016.22 [Crossref] [Google Scholar]
  49. Ikegami N. Financing long-term care: lessons from Japan. Int J Health Policy Manag 2019; 8(8):462-466. doi: 10.15171/ijhpm.2019.35 [Crossref] [ Google Scholar]
  50. Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Improving the quality and quantity of HIV Data in the Middle East and North Africa: key challenges and ways forward. Int J Health Policy Manag 2017; 6(2):65-69. doi: 10.15171/ijhpm.2016.112 [Crossref] [ Google Scholar]
  51. Kickbusch I. Global health governance challenges 2016 - are we ready?. Int J Health Policy Manag 2016; 5(6):349-353. doi: 10.15171/ijhpm.2016.27 [Crossref] [ Google Scholar]
  52. Labonté R. Health promotion in an age of normative equity and rampant inequality. Int J Health Policy Manag2016; 5(12):675-682. doi: 10.15171/ijhpm.2016.95 [Crossref] [ Google Scholar]
  53. Labonté R. Ensuring global health equity in a post-pandemic economy. Int J Health Policy Manag 2022; 11(8):1246-1250. doi: 10.34172/ijhpm.2022.7212 [Crossref] [ Google Scholar]
  54. Lunt N, Mannion R. Patient mobility in the global marketplace: a multidisciplinary perspective. Int J Health Policy Manag 2014; 2(4):155-157. doi: 10.15171/ijhpm.2014.47 [Crossref] [ Google Scholar]
  55. Luo Z, Fabre G, Rodwin VG. Meeting the challenge of diabetes in China. Int J Health Policy Manag 2020; 9(2):47-52. doi: 10.15171/ijhpm.2019.80 [Crossref] [ Google Scholar]
  56. Mannion R, Braithwaite J. False dawns and new horizons in patient safety research and practice. Int J Health Policy Manag 2017; 6(12):685-689. doi: 10.15171/ijhpm.2017.115 [Crossref] [ Google Scholar]
  57. Mannion R, Davies HT. Cultures of silence and cultures of voice: the role of whistleblowing in healthcare organisations. Int J Health Policy Manag 2015; 4(8):503-505. doi: 10.15171/ijhpm.2015.120 [Crossref] [ Google Scholar]
  58. Mannion R, Exworthy M. (Re) making the procrustean bed? Standardization and customization as competing logics in healthcare. Int J Health Policy Manag 2017; 6(6):301-304. doi: 10.15171/ijhpm.2017.35 [Crossref] [ Google Scholar]
  59. Mannion R, Small N. On folk devils, moral panics and new wave public health. Int J Health Policy Manag 2019; 8(12):678-683. doi: 10.15171/ijhpm.2019.78 [Crossref] [ Google Scholar]
  60. McDonald R. Leadership and leadership development in healthcare settings - a simplistic solution to complex problems?. Int J Health Policy Manag 2014; 3(5):227-229. doi: 10.15171/ijhpm.2014.101 [Crossref] [ Google Scholar]
  61. McKee M, Stuckler D. Reflective practice: how the World Bank explored its own biases?. Int J Health Policy Manag2015; 5(2):79-82. doi: 10.15171/ijhpm.2015.216 [Crossref] [ Google Scholar]
  62. Mesgarpour B, Aghababa S, Baradaran HR. Achievements of the Cochrane Iran Associate Centre: lessons learned. Int J Health Policy Manag 2020; 9(6):222-228. doi: 10.15171/ijhpm.2019.122 [Crossref] [ Google Scholar]
  63. Mialon M, Fooks G, Cullerton K. Corporations and health: the need to combine forces to improve population health. Int J Health Policy Manag 2022; 11(7):871-873. doi: 10.34172/ijhpm.2022.6687 [Crossref] [ Google Scholar]
  64. Michelo C, Hurtig AK, Schneider H. Working towards inclusive, socially accountable and resilient community health systems: an introduction to a special issue. Int J Health Policy Manag 2022; 11(1):1-4. doi: 10.34172/ijhpm.2021.166 [Crossref] [ Google Scholar]
  65. Moradi-Lakeh M, Vosoogh-Moghaddam A. Health sector evolution plan in Iran; equity and sustainability concerns. Int J Health Policy Manag 2015; 4(10):637-640. doi: 10.15171/ijhpm.2015.160 [Crossref] [ Google Scholar]
  66. Norheim OF. A grand convergence in mortality is possible: Comment on Global health 2035. Int J Health Policy Manag 2014; 2(1):1-3. doi: 10.15171/ijhpm.2014.01 [Crossref] [ Google Scholar]
  67. Norheim OF. Ethical perspective: five unacceptable trade-offs on the path to universal health coverage. Int J Health Policy Manag 2015; 4(11):711-714. doi: 10.15171/ijhpm.2015.184 [Crossref] [ Google Scholar]
  68. Norheim OF. Disease control priorities third edition is published: a theory of change is needed for translating evidence to health policy. Int J Health Policy Manag 2018; 7(9):771-777. doi: 10.15171/ijhpm.2018.60 [Crossref] [Google Scholar]
  69. Paton CR. The politics and analytics of health policy. Int J Health Policy Manag 2014; 2(3):105-107. doi: 10.15171/ijhpm.2014.26 [Crossref] [ Google Scholar]
  70. Powell M, Mannion R. Modelling the health policy process: one size fits all or horses for courses?. Int J Health Policy Manag 2023; 12:7580. doi: 10.34172/ijhpm.2022.7580 [Crossref] [ Google Scholar]
  71. Roache SA, Gostin LO. The untapped power of soda taxes: incentivizing consumers, generating revenue, and altering corporate behavior. Int J Health Policy Manag 2017; 6(9):489-493. doi: 10.15171/ijhpm.2017.69 [Crossref] [Google Scholar]
  72. Rodwin VG, Fabre G, Ayoub RF. BRIC health systems and Big Pharma: a challenge for health policy and management. Int J Health Policy Manag 2018; 7(3):201-206. doi: 10.15171/ijhpm.2017.145 [Crossref] [ Google Scholar]
  73. Rycroft-Malone J, Burton CR, Bucknall T, Graham ID, Hutchinson AM, Stacey D. Collaboration and co-production of knowledge in healthcare: opportunities and challenges. Int J Health Policy Manag 2016; 5(4):221-223. doi: 10.15171/ijhpm.2016.08 [Crossref] [ Google Scholar]
  74. Shiffman J. Knowledge, moral claims and the exercise of power in global health. Int J Health Policy Manag 2014; 3(6):297-299. doi: 10.15171/ijhpm.2014.120 [Crossref] [ Google Scholar]
  75. Shiffman J. Four challenges that global health networks face. Int J Health Policy Manag 2017; 6(4):183-189. doi: 10.15171/ijhpm.2017.14 [Crossref] [ Google Scholar]
  76. Shiffman J. Agency, structure and the power of global health networks. Int J Health Policy Manag 2018; 7(10):879-884. doi: 10.15171/ijhpm.2018.71 [Crossref] [ Google Scholar]
  77. Speed E, Mannion R. The rise of post-truth populism in pluralist liberal democracies: challenges for health policy. Int J Health Policy Manag 2017; 6(5):249-251. doi: 10.15171/ijhpm.2017.19 [Crossref] [ Google Scholar]
  78. Takian A, Kazempour-Ardebili S. Diabetes dictating policy: an editorial commemorating world health day 2016. Int J Health Policy Manag 2016; 5(10):571-573. doi: 10.15171/ijhpm.2016.79 [Crossref] [ Google Scholar]
  79. Takian A, Mousavi A, McKee M. COP27: the prospects and challenges for the Middle East and North Africa (MENA). Int J Health Policy Manag 2022; 11(12):2776-2779. doi: 10.34172/ijhpm.2022.7800 [Crossref] [ Google Scholar]
  80. Tangcharoensathien V, Chandrasiri O, Kunpeuk W, Markchang K, Pangkariya N. Addressing NCDs: challenges from industry market promotion and interferences. Int J Health Policy Manag 2019; 8(5):256-260. doi: 10.15171/ijhpm.2019.02 [Crossref] [ Google Scholar]
  81. Tangcharoensathien V, Patcharanarumol W, Suwanwela W. Defining the benefit package of Thailand universal coverage scheme: from pragmatism to sophistication. Int J Health Policy Manag 2020; 9(4):133-137. doi: 10.15171/ijhpm.2019.96 [Crossref] [ Google Scholar]
  82. Tangcharoensathien V, Srisookwatana O, Pinprateep P, Posayanonda T, Patcharanarumol W. Multisectoral actions for health: challenges and opportunities in complex policy environments. Int J Health Policy Manag 2017; 6(7):359-363. doi: 10.15171/ijhpm.2017.61 [Crossref] [ Google Scholar]
  83. Yang Q, Dong H. Have health human resources become more equal between rural and urban areas after the new reform?. Int J Health Policy Manag 2014; 3(7):359-360. doi: 10.15171/ijhpm.2014.129 [Crossref] [ Google Scholar]
  84. Carmichael JL, Karamouzian M. Deadly professions: violent attacks against aid-workers and the health implications for local populations. Int J Health Policy Manag 2014; 2(2):65-67. doi: 10.15171/ijhpm.2014.16 [Crossref] [ Google Scholar]
  85. Hategekimana C, Karamouzian M. Self-perceived mental health status and uptake of fecal occult blood test for colorectal cancer screening in Canada: a cross-sectional study. Int J Health Policy Manag 2016; 5(6):365-371. doi: 10.15171/ijhpm.2016.14 [Crossref] [ Google Scholar]
  86. Hosseini Hooshyar S, Karamouzian M, Mirzazadeh A, Haghdoost AA, Sharifi H, Shokoohi M. Condom use and its associated factors among Iranian youth: results from a population-based study. Int J Health Policy Manag 2018; 7(11):1007-1014. doi: 10.15171/ijhpm.2018.65 [Crossref] [ Google Scholar]
  87. Karamouzian M. Trump’s zero-tolerance policy: would a political response to a humanitarian crisis work?. Int J Health Policy Manag 2018; 7(11):1070-1072. doi: 10.15171/ijhpm.2018.80 [Crossref] [ Google Scholar]
  88. Karamouzian M, Haghdoost AA, Sharifi H. Addressing the needs of sexual partners of people who inject drugs through peer prevention programs in Iran. Int J Health Policy Manag 2014; 2(2):81-83. doi: 10.15171/ijhpm.2014.19 [Crossref] [ Google Scholar]
  89. Karamouzian M, Hategekimana C. Ebola treatment and prevention are not the only battles: understanding Ebola-related fear and stigma. Int J Health Policy Manag 2015; 4(1):55-56. doi: 10.15171/ijhpm.2014.128 [Crossref] [Google Scholar]
  90. Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Tackling HIV in MENA: talk is not Enough-It is time for bold actions: a response to recent commentaries. Int J Health Policy Manag 2018; 7(2):199-200. doi: 10.15171/ijhpm.2017.110 [Crossref] [ Google Scholar]
  91. Karamouzian M, Sharifi H, Haghdoost AA. Iran’s shift in family planning policies: concerns and challenges. Int J Health Policy Manag 2014; 3(5):231-233. doi: 10.15171/ijhpm.2014.81 [Crossref] [ Google Scholar]
  92. Nasirian M, Hosseini Hooshyar S, Haghdoost AA, Karamouzian M. How and where do we ask sensitive questions: self-reporting of STI-associated symptoms among the Iranian general population. Int J Health Policy Manag 2018; 7(8):738-745. doi: 10.15171/ijhpm.2018.18 [Crossref] [ Google Scholar]
  93. Nasirian M, Karamouzian M, Kamali K. Care seeking patterns of STIs-associated symptoms in Iran: findings of a population-based survey. Int J Health Policy Manag 2015; 5(1):5-11. doi: 10.15171/ijhpm.2015.146 [Crossref] [Google Scholar]
  94. Nasirian M, Kianersi S, Karamouzian M. HIV modes of transmission in Sudan in 2014. Int J Health Policy Manag2020; 9(3):108-115. doi: 10.15171/ijhpm.2019.91 [Crossref] [ Google Scholar]
  95. Rastegari A, Baneshi MR, Hajebi A. Population size estimation of people who use illicit drugs and alcohol in Iran (2015-2016). Int J Health Policy Manag 2022; 12:6578. doi: 10.34172/ijhpm.2022.6578 [Crossref] [ Google Scholar]
  96. Sharifi H, Jahani Y, Mirzazadeh A. Estimating COVID-19-Related infections, deaths, and hospitalizations in Iran under different physical distancing and isolation scenarios. Int J Health Policy Manag 2022; 11(3):334-343. doi: 10.34172/ijhpm.2020.134 [Crossref] [ Google Scholar]
  97. Sharifi H, Karamouzian M. Introducing ‘One Health’ as an overlooked concept in Iran. Int J Health Policy Manag2014; 2(2):101-102. doi: 10.15171/ijhpm.2014.24 [Crossref] [ Google Scholar]
  98. Tavakoli F, Karamouzian M, Rafiei-Rad AA. HIV-related stigma among healthcare providers in different healthcare settings: a cross-sectional study in Kerman, Iran. Int J Health Policy Manag 2020; 9(4):163-169. doi: 10.15171/ijhpm.2019.92 [Crossref] [ Google Scholar]
  99. Vahidi M, Jalilian Khave L, Sanadgol G, Shirini D, Karamouzian M. Student-led initiatives’ potential in the COVID-19 response in Iran. Int J Health Policy Manag 2020; 9(10):464-465. doi: 10.34172/ijhpm.2020.82 [Crossref] [ Google Scholar]
  100. Mannion R. Enabling compassionate healthcare: perils, prospects and perspectives. Int J Health Policy Manag2014; 2(3):115-117. doi: 10.15171/ijhpm.2014.34 [Crossref] [ Google Scholar]
  101. Sanderson J, Lonsdale C, Mannion R. Inside the black box: organisational buying behaviour and strategic purchasing in healthcare: a response to recent commentary. Int J Health Policy Manag 2019; 8(11):675-677. doi: 10.15171/ijhpm.2019.70 [Crossref] [ Google Scholar]
  102. Speed E, Mannion R. The politics and power of populism: a response to the recent commentaries. Int J Health Policy Manag 2018; 7(4):365-366. doi: 10.15171/ijhpm.2017.118 [Crossref] [ Google Scholar]
  103. Mannion R, Exworthy M. Researching the co-existence and continuity of standardization and customization in healthcare: a response to recent commentaries. Int J Health Policy Manag 2018; 7(6):572-573. doi: 10.15171/ijhpm.2018.07 [Crossref] [ Google Scholar]
  104. Mannion R. Take the money and run: the challenges of designing and evaluating financial incentives in healthcare: Comment on “Paying for performance in healthcare organisations. ” Int J Health Policy Manag 2014; 2(2):95-96. doi: 10.15171/ijhpm.2014.22 [Crossref] [ Google Scholar]
  105. Sanderson J, Lonsdale C, Mannion R. What’s needed to develop strategic purchasing in healthcare? Policy lessons from a realist review. Int J Health Policy Manag 2019; 8(1):4-17. doi: 10.15171/ijhpm.2018.93 [Crossref] [ Google Scholar]
  106. Mannion R, Braithwaite J. Where is patient safety research and practice heading? A response to recent commentaries. Int J Health Policy Manag 2019; 8(2):136-137. doi: 10.15171/ijhpm.2018.112 [Crossref] [ Google Scholar]
  107. Mannion R, Davies HT. Whistleblowing in the wind towards a socially situated research agenda: a response to recent commentaries. Int J Health Policy Manag 2016; 5(6):395-396. doi: 10.15171/ijhpm.2016.34 [Crossref] [Google Scholar]
  108. Haghdoost AA, Ashrafi Asgar-Abad A, Shokoohi M, Alam M, Esmaeili M, Hojabri N. How do students conceptualise health and its risk factors? A study among Iranian schoolchildren. Int J Health Policy Manag 2013; 1(1):35-42. doi: 10.15171/ijhpm.2013.06 [Crossref] [ Google Scholar]
  109. Haji-Maghsoudi S, Haghdoost AA, Rastegari A, Baneshi MR. Influence of pattern of missing data on performance of imputation methods: an example using national data on drug injection in prisons. Int J Health Policy Manag2013; 1(1):69-77. doi: 10.15171/ijhpm.2013.11 [Crossref] [ Google Scholar]
  110. Mohebbi E, Haghdoost AA, Noroozi A. Awareness and attitude towards opioid and stimulant use and lifetime prevalence of the drugs: a study in 5 large cities of Iran. Int J Health Policy Manag 2019; 8(4):222-232. doi: 10.15171/ijhpm.2018.128 [Crossref] [ Google Scholar]
  111. Nikfarjam A, Haji-Maghsoudi S, Rastegari A. The frequency of alcohol use in Iranian urban population: the results of a national network scale up survey. Int J Health Policy Manag 2017; 6(2):97-102. doi: 10.15171/ijhpm.2016.103 [Crossref] [ Google Scholar]
  112. Noori A, Shokoohi M, Baneshi MR, Naderi N, Bakhshandeh H, Haghdoost AA. Impact of socio-economic status on the hospital readmission of congestive heart failure patients: a prospective cohort study. Int J Health Policy Manag2014; 3(5):251-257. doi: 10.15171/ijhpm.2014.94 [Crossref] [ Google Scholar]
  113. Labonté R. Framing political change: can a left populism disrupt the rise of the reactionary right? Comment on “Politics, power, poverty and global health: systems and frames. ” Int J Health Policy Manag 2017; 6(9):547-549. doi: 10.15171/ijhpm.2017.08 [Crossref] [ Google Scholar]
  114. Labonté R. From mid-level policy analysis to macro-level political economy: Comment on “Developing a framework for a program theory-based approach to evaluating policy processes and outcomes: health in all policies in South Australia. ” Int J Health Policy Manag 2018; 7(7):656-658. doi: 10.15171/ijhpm.2018.12 [Crossref] [Google Scholar]
  115. Labonté R. From the myth of level playing fields to the reality of a finite planet: Comment on “A global social support system: what the international community could learn from the United States’ National Basketball Association’s scheme for redistribution of new talent. ” Int J Health Policy Manag 2015; 5(2):137-139. doi: 10.15171/ijhpm.2015.202 [Crossref] [ Google Scholar]
  116. Bergen N, Ruckert A, Labonté R. Monitoring frameworks for universal health coverage: what about high-income countries?. Int J Health Policy Manag 2019; 8(7):387-393. doi: 10.15171/ijhpm.2019.21 [Crossref] [ Google Scholar]
  117. Labonté R. Neoliberalism 4.0: the rise of illiberal capitalism: Comment on “How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention.”. Int J Health Policy Manag 2020; 9(4):175-178. doi: 10.15171/ijhpm.2019.111 [Crossref] [ Google Scholar]
  118. Labonté R. Purveyors of the commercial determinants of health have no place at any policy table: Comment on “Towards preventing and managing conflict of interest in nutrition policy? An analysis of submissions to a consultation on a draft WHO tool. ” Int J Health Policy Manag 2022; 11(2):243-245. doi: 10.34172/ijhpm.2020.171 [Crossref] [ Google Scholar]
  119. Labonté R, Baum F. Right wing politics and public policy: the need for a broad frame and further research: Comment on “A scoping review of populist radical right parties’ influence on welfare policy and its implications for population health in Europe. ” Int J Health Policy Manag 2021; 10(8):519-522. doi: 10.34172/ijhpm.2020.137 [Crossref] [ Google Scholar]
  120. Labonté R, Schram A, Ruckert A. The TPP is dead, long live the TPP? A response to recent commentaries. Int J Health Policy Manag 2017; 6(4):245-247. doi: 10.15171/ijhpm.2017.12 [Crossref] [ Google Scholar]
  121. Labonté R, Schram A, Ruckert A. The Trans-Pacific Partnership: is it everything we feared for health?. Int J Health Policy Manag 2016; 5(8):487-496. doi: 10.15171/ijhpm.2016.41 [Crossref] [ Google Scholar]
  122. Townsend B, Friel S, Schram A, Baum F, Labonté R. What generates attention to health in trade policy-making? Lessons from success in tobacco control and access to medicines: a qualitative study of Australia and the (comprehensive and progressive) Trans-Pacific Partnership. Int J Health Policy Manag 2021; 10(10):613-624. doi: 10.34172/ijhpm.2020.80 [Crossref] [ Google Scholar]
  123. McKee M, Gugushvili A, Koltai J, Stuckler D. Are populist leaders creating the conditions for the spread of COVID-19? Comment on “A scoping review of populist radical right parties’ influence on welfare policy and its implications for population health in Europe. ” Int J Health Policy Manag 2021; 10(8):511-515. doi: 10.34172/ijhpm.2020.124 [Crossref] [ Google Scholar]
  124. Hutchinson E, Balabanova D, McKee M. Beyond talking: we need effective measures to tackle systemic corruption and the power that allows it to persist in health systems; a response to recent commentaries. Int J Health Policy Manag 2020; 9(12):536-538. doi: 10.15171/ijhpm.2020.21 [Crossref] [ Google Scholar]
  125. McKee M. Bridging the gap between research and policy and practice comment on “CIHR health system impact fellows: reflections on ‘driving change’ within the health system. ” Int J Health Policy Manag 2019; 8(9):557-559. doi: 10.15171/ijhpm.2019.46 [Crossref] [ Google Scholar]
  126. McKee M, Wouters OJ. The challenges of regulating artificial intelligence in healthcare: Comment on “Clinical decision support and new regulatory frameworks for medical devices: are we ready for it? - A viewpoint paper.” Int J Health Policy Manag 2022;12. 10.34172/ijhpm.2022.7261.
  127. McKee M, Stuckler D. “Enemies of the people?” Public health in the era of populist politics: Comment on “The rise of post-truth populism in pluralist liberal democracies: challenges for health policy. ” Int J Health Policy Manag2017; 6(11):669-672. doi: 10.15171/ijhpm.2017.46 [Crossref] [ Google Scholar]
  128. Morris M, Seguin M, Landon S, McKee M, Nolte E. Exploring the role of leadership in facilitating change to improve cancer survival: an analysis of experiences in seven high income countries in the International Cancer Benchmarking Partnership (ICBP). Int J Health Policy Manag 2021; 11(9):1756-1766. doi: 10.34172/ijhpm.2021.84 [Crossref] [ Google Scholar]
  129. Abba-Aji M, Balabanova D, Hutchinson E, McKee M. How do Nigerian newspapers report corruption in the health system?. Int J Health Policy Manag 2021; 10(2):77-85. doi: 10.34172/ijhpm.2020.37 [Crossref] [ Google Scholar]
  130. Brathwaite R, Hutchinson E, McKee M, Palafox B, Balabanova D. The long and winding road: a systematic literature review conceptualising pathways for hypertension care and control in low- and middle-income countries. Int J Health Policy Manag 2022; 11(3):257-268. doi: 10.34172/ijhpm.2020.105 [Crossref] [ Google Scholar]
  131. Binyaruka P, Andreoni A, Balabanova D, McKee M, Hutchinson E, Angell B. Re-aligning incentives to address informal payments in Tanzania public health facilities: a discrete choice experiment. Int J Health Policy Manag2023; 12:6877. doi: 10.34172/ijhpm.2022.6877 [Crossref] [ Google Scholar]
  132. Paltiel O, Hailu W, Abay Z, Clarfield AM, McKee M. “Sell an Ox” - the price of cure for hepatitis C in two countries. Int J Health Policy Manag 2020; 9(6):229-232. doi: 10.15171/ijhpm.2019.135 [Crossref] [ Google Scholar]
  133. Seguin M, Morris M, McKee M, Nolte E. “There’s not enough bodies to do the demand:” an exploration of key stakeholder views on the role of health service capacity in shaping cancer outcomes in 7 International Cancer Benchmarking Partnership countries. Int J Health Policy Manag 2020; 11(7):1024-1034. doi: 10.34172/ijhpm.2020.254 [Crossref] [ Google Scholar]
  134. Onwujekwe O, Orjiakor CT, Hutchinson E. Where do we start? Building consensus on drivers of health sector corruption in Nigeria and ways to address it. Int J Health Policy Manag 2020; 9(7):286-296. doi: 10.15171/ijhpm.2019.128 [Crossref] [ Google Scholar]
  135. Jeurissen PP, Maarse H. New provider models for Sweden and Spain: public, private or non-profit? Comment on “Governance, government, and the search for new provider models. ” Int J Health Policy Manag 2016; 5(12):721-723. doi: 10.15171/ijhpm.2016.87 [Crossref] [ Google Scholar]
  136. van der Wees PJ, Wammes JJ, Westert GP, Jeurissen PP. The relationship between the scope of essential health benefits and statutory financing: an international comparison across eight European countries. Int J Health Policy Manag 2015; 5(1):13-22. doi: 10.15171/ijhpm.2015.166 [Crossref] [ Google Scholar]
  137. van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Medicalisation and overdiagnosis: what society does to medicine. Int J Health Policy Manag 2016; 5(11):619-622. doi: 10.15171/ijhpm.2016.121 [Crossref] [ Google Scholar]
  138. Mosca I, van der Wees PJ, Mot ES, Wammes JJG, Jeurissen PP. Sustainability of long-term care: puzzling tasks ahead for policy-makers. Int J Health Policy Manag 2017; 6(4):195-205. doi: 10.15171/ijhpm.2016.109 [Crossref] [Google Scholar]
  139. van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Define and conquer: how semantics foster progress; a response to recent commentaries. Int J Health Policy Manag 2017; 6(11):681-682. doi: 10.15171/ijhpm.2017.116 [Crossref] [ Google Scholar]
  140. Auener S, Kroon D, Wackers E, van Dulmen S, Jeurissen PP. COVID-19: a window of opportunity for positive healthcare reforms. Int J Health Policy Manag 2020; 9(10):419-422. doi: 10.34172/ijhpm.2020.66 [Crossref] [Google Scholar]
  141. Kruse FM, Jeurissen PP. For-profit hospitals out of business? Financial sustainability during the COVID-19 epidemic emergency response. Int J Health Policy Manag 2020; 9(10):423-428. doi: 10.34172/ijhpm.2020.67 [Crossref] [ Google Scholar]
  142. Tulp AD, Kruse FM, Stadhouders NW, Jeurissen PP. Independent treatment centres are not a guarantee for high quality and low healthcare prices in the Netherlands - a study of 5 elective surgeries. Int J Health Policy Manag2020; 9(9):380-389. doi: 10.15171/ijhpm.2019.144 [Crossref] [ Google Scholar]
  143. van Dijk W, Meinders MJ, Tanke MA, Westert GP, Jeurissen PP. Medicalization defined in empirical contexts - a scoping review. Int J Health Policy Manag 2020; 9(8):327-334. doi: 10.15171/ijhpm.2019.101 [Crossref] [ Google Scholar]
  144. Jeurissen PP, Klazinga N, Hagenaars L. Complex governance does increase both the real and perceived registration burden: the case of the Netherlands: Comment on “Perceived burden due to registrations for quality monitoring and improvement in hospitals: a mixed methods study. ” Int J Health Policy Manag 2022; 11(4):533-535. doi: 10.34172/ijhpm.2020.264 [Crossref] [ Google Scholar]
  145. Vlaanderen FP, de Man Y, Tanke MA. Density of patient-sharing networks: impact on the value of Parkinson care. Int J Health Policy Manag 2021; 11(7):1132-1139. doi: 10.34172/ijhpm.2021.15 [Crossref] [ Google Scholar]
  146. Wackers E, Stadhouders N, Heil A, Westert G, van Dulmen S, Jeurissen P. Hospitals bending the cost curve with increased quality: a scoping review into integrated hospital strategies. Int J Health Policy Manag 2021; 11(11):2381-2391. doi: 10.34172/ijhpm.2021.168 [Crossref] [ Google Scholar]
  147. Jansen MP, Baltussen R, Mikkelsen E. Evidence-informed deliberative processes - early dialogue, broad focus and relevance: a response to recent commentaries. Int J Health Policy Manag 2018; 7(1):96-97. doi: 10.15171/ijhpm.2017.88 [Crossref] [ Google Scholar]
  148. Gajewski J, Brugha R, Bijlmakers L. Global surgery priorities: a response to recent commentaries. Int J Health Policy Manag 2019; 8(6):381-383. doi: 10.15171/ijhpm.2019.10 [Crossref] [ Google Scholar]
  149. Bijlmakers L. Systems science and evidence-informed deliberation to mitigate dilemmas in situations of dual agency at the hospital level: Comment on “Dual agency in hospitals: what strategies do managers and physicians apply to reconcile dilemmas between clinical and economic considerations. ” Int J Health Policy Manag 2022; 11(10):2337-2339. doi: 10.34172/ijhpm.2022.6940 [Crossref] [ Google Scholar]
  150. Broekhuizen H, Ifeanyichi M, Mwapasa G. Improving access to surgery through surgical team mentoring - policy lessons from group model building with local stakeholders in Malawi. Int J Health Policy Manag 2021; 11(9):1744-1755. doi: 10.34172/ijhpm.2021.78 [Crossref] [ Google Scholar]
  151. Broekhuizen H, Lansu M, Gajewski J. Using group model building to capture the complex dynamics of scaling up district-level surgery in Arusha region, Tanzania. Int J Health Policy Manag 2020; 11(7):981-989. doi: 10.34172/ijhpm.2020.249 [Crossref] [ Google Scholar]
  152. Gajewski J, Wallace M, Pittalis C. Why do they leave? Challenges to retention of surgical clinical officers in district hospitals in Malawi. Int J Health Policy Manag 2022; 11(3):354-361. doi: 10.34172/ijhpm.2020.142 [Crossref] [Google Scholar]
  153. Ifeanyichi M, Broekhuizen H, Juma A. Economic costs of providing district- and regional-level surgeries in Tanzania. Int J Health Policy Manag 2021; 11(7):1120-1131. doi: 10.34172/ijhpm.2021.09 [Crossref] [ Google Scholar]
  154. Jansen M, Baltussen R, Bijlmakers L, Tummers M. The Dutch Citizen Forum on public reimbursement of healthcare: a qualitative analysis of opinion change. Int J Health Policy Manag 2022; 11(2):118-127. doi: 10.34172/ijhpm.2020.81 [Crossref] [ Google Scholar]
  155. Nouhi M, Baltussen R, Razavi SS. The use of evidence-informed deliberative processes for health insurance benefit package revision in Iran. Int J Health Policy Manag 2022; 11(11):2719-2726. doi: 10.34172/ijhpm.2022.6485 [Crossref] [ Google Scholar]
  156. Pittalis C, Brugha R, Bijlmakers L. Using network and complexity theories to understand the functionality of referral systems for surgical patients in resource-limited settings, the case of Malawi. Int J Health Policy Manag2021; 11(11):2502-2513. doi: 10.34172/ijhpm.2021.175 [Crossref] [ Google Scholar]
  157. Brugha R, Bruen C. Politics matters: a response to recent commentaries. Int J Health Policy Manag 2014; 3(3):157-158. doi: 10.15171/ijhpm.2014.80 [Crossref] [ Google Scholar]
  158. Brugha R, Clarke N, Hendrick L, Sweeney J. Doctor retention: a cross-sectional study of how Ireland has been losing the battle. Int J Health Policy Manag 2021; 10(6):299-309. doi: 10.34172/ijhpm.2020.54 [Crossref] [ Google Scholar]
  159. Brugha R. Doctor retention in a COVID-world: an opportunity to reconfigure the health workforce, or “Plus ça change plus c’est la meme chose”? A response to the recent commentaries. Int J Health Policy Manag 2022; 11(6):865-868. doi: 10.34172/ijhpm.2021.60 [Crossref] [ Google Scholar]
  160. Baum F, Anaf J. A world beyond transnational corporations: meeting human rather than corporate need: Comment on “’Part of the solution’: food corporation strategies for regulatory capture and legitimacy. ” Int J Health Policy Manag 2022; 11(11):2748-2751. doi: 10.34172/ijhpm.2022.7540 [Crossref] [ Google Scholar]
  161. Baum F, Freeman T. Why community health systems have not flourished in high income countries: what the australian experience tells us. Int J Health Policy Manag 2022; 11(1):49-58. doi: 10.34172/ijhpm.2021.42 [Crossref] [Google Scholar]
  162. Baum F, Townsend B, Fisher M. Creating political will for action on health equity: practical lessons for public health policy actors. Int J Health Policy Manag 2020; 11(7):947-960. doi: 10.34172/ijhpm.2020.233 [Crossref] [Google Scholar]
  163. Fisher M, Freeman T, Mackean T, Friel S, Baum F. Universal health coverage for health equity: from principle to practice; a response to the recent commentaries. Int J Health Policy Manag 2022; 11(8):1601-1603. doi: 10.34172/ijhpm.2022.7218 [Crossref] [ Google Scholar]
  164. Fisher M, Freeman T, Mackean T, Friel S, Baum F. Universal health coverage for non-communicable diseases and health equity: lessons from Australian primary healthcare. Int J Health Policy Manag 2022; 11(5):690-700. doi: 10.34172/ijhpm.2020.232 [Crossref] [ Google Scholar]
  165. Fisher M, Harris P, Freeman T. Implementing universal and targeted policies for health equity: lessons from Australia. Int J Health Policy Manag 2021; 11(10):2308-2318. doi: 10.34172/ijhpm.2021.157 [Crossref] [ Google Scholar]
  166. Javanparast S, Baum F, Ziersch A, Freeman T. A framework to determine the extent to which regional primary healthcare organisations are comprehensive or selective in their approach. Int J Health Policy Manag 2022; 11(4):479-488. doi: 10.34172/ijhpm.2020.182 [Crossref] [ Google Scholar]
  167. Mateos JT, Fernández-Sáez J, Marcos-Marcos J. Gender equality and the global gender gap in life expectancy: an exploratory analysis of 152 countries. Int J Health Policy Manag 2022; 11(6):740-746. doi: 10.34172/ijhpm.2020.192 [Crossref] [ Google Scholar]
  168. Baum F, McGreevy MP, MacDougall CM, Henley M. Energy as a social and commercial determinant of health: a qualitative study of Australian policy. Int J Health Policy Manag 2023; 12:7193. doi: 10.34172/ijhpm.2022.7193 [Crossref] [ Google Scholar]
  169. Jansen MP, Helderman JK, Boer B, Baltussen R. Fair processes for priority setting: putting theory into practice: Comment on “Expanded HTA: enhancing fairness and legitimacy. ” Int J Health Policy Manag 2017; 6(1):43-47. doi: 10.15171/ijhpm.2016.85 [Crossref] [ Google Scholar]
  170. Seixas BV, Mitton C, Danis M, Williams I, Gold M, Baltussen R. Should priority setting also be concerned about profound socio-economic transformations? A response to recent commentary. Int J Health Policy Manag 2017; 6(12):733-734. doi: 10.15171/ijhpm.2017.85 [Crossref] [ Google Scholar]
  171. Jansen MP, Baltussen R, Bærøe K. Stakeholder participation for legitimate priority setting: a checklist. Int J Health Policy Manag 2018; 7(11):973-976. doi: 10.15171/ijhpm.2018.57 [Crossref] [ Google Scholar]
  172. Oortwijn W, Jansen M, Baltussen R. Use of evidence-informed deliberative processes by health technology assessment agencies around the globe. Int J Health Policy Manag 2020; 9(1):27-33. doi: 10.15171/ijhpm.2019.72 [Crossref] [ Google Scholar]
  173. Baltussen R, Jansen M, Oortwijn W. Evidence-informed deliberative processes for legitimate health benefit package design - part I: conceptual framework. Int J Health Policy Manag 2021; 11(10):2319-2326. doi: 10.34172/ijhpm.2021.158 [Crossref] [ Google Scholar]
  174. Oortwijn W, Jansen M, Baltussen R. Evidence-informed deliberative processes for health benefit package design - part II: a practical guide. Int J Health Policy Manag 2021; 11(10):2327-2336. doi: 10.34172/ijhpm.2021.159 [Crossref] [ Google Scholar]
  175. Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014; 3(3):123-128. doi: 10.15171/ijhpm.2014.71 [Crossref] [ Google Scholar]

Files

History

  • Receive Date: 11 May 2023
  • Revise Date: 21 May 2023
  • Accept Date: 23 May 2023
  • First Publish Date: 24 May 2023

Share

How to cite

Statistics